<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://ccpem.blog/wp-content/plugins/seriously-simple-podcasting/templates/feed-stylesheet.xsl"?><rss version="2.0"
	 xmlns:content="http://purl.org/rss/1.0/modules/content/"
	 xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	 xmlns:dc="http://purl.org/dc/elements/1.1/"
	 xmlns:atom="http://www.w3.org/2005/Atom"
	 xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	 xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	 xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
	 xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0"
	 xmlns:podcast="https://podcastindex.org/namespace/1.0"
	
	xmlns:georss="http://www.georss.org/georss"
	xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#"
	>
		<channel>
		<title>Critical Care Perspectives in Emergency Medicine</title>
		<atom:link href="https://ccpem.blog/feed/podcast/" rel="self" type="application/rss+xml"/>
		<link>https://ccpem.blog/</link>
		<description>Critical Care Guys: The Minds Behind Critical Care Perspectives in Emergency Medicine. 4 Docs come together to discuss current trends in Emergency Medicine. Check out this podcast to stay up-to-date on the goings ons.</description>
		<lastBuildDate>Thu, 12 Mar 2026 20:30:32 +0000</lastBuildDate>
		<language>en-US</language>
		<copyright></copyright>
		<itunes:subtitle></itunes:subtitle>
		<itunes:author>Critical Care Perspectives in Emergency Medicine</itunes:author>
		<itunes:type>episodic</itunes:type>
		<itunes:summary>Critical Care Guys: The Minds Behind Critical Care Perspectives in Emergency Medicine. 4 Docs come together to discuss current trends in Emergency Medicine. Check out this podcast to stay up-to-date on the goings ons.</itunes:summary>
		<itunes:owner>
			<itunes:name>Critical Care Perspectives in Emergency Medicine</itunes:name>
			<itunes:email>ccpemergencymedicine@gmail.com</itunes:email>
		</itunes:owner>
		<itunes:explicit>clean</itunes:explicit>
		<itunes:category text="Health &amp; Fitness">
			<itunes:category text="Medicine"></itunes:category>
		</itunes:category>
		<itunes:category text="Education">
							</itunes:category>
		<podcast:locked owner="ccpemergencymedicine@gmail.com">yes</podcast:locked>
		<podcast:guid>60a10b8a-6b33-5e3f-a960-e32c17f5c2e1</podcast:guid>
		
		<!-- podcast_generator="SSP by Castos/2.20.3" Seriously Simple Podcasting plugin for WordPress (https://wordpress.org/plugins/seriously-simple-podcasting/) -->
		<generator>https://wordpress.org/?v=6.2.9</generator>
<site xmlns="com-wordpress:feed-additions:1">171586925</site>
<item>
	<title>Is This Patient Volume Overloaded?</title>
	<link>https://ccpem.blog/podcast/is-this-patient-volume-overloaded/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=is-this-patient-volume-overloaded&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=is-this-patient-volume-overloaded</link>
	<pubDate>Thu, 12 Mar 2026 18:03:46 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=2114</guid>
	<description><![CDATA[<p>Accurate assessment of intravascular volume is critical in managing sick patients in the emergency department or intensive care unit.   In this podcast we discuss a recently published article that evaluates clinical exam, radiographic, point-of-care ultrasound, and laboratory findings in the assessment of intravascular volume overload.</p>]]></description>
	<itunes:subtitle><![CDATA[Accurate assessment of intravascular volume is critical in managing sick patients in the emergency department or intensive care unit.   In this podcast we discuss a recently published article that evaluates clinical exam, radiographic, point-of-care ultr]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Accurate assessment of intravascular volume is critical in managing sick patients in the emergency department or intensive care unit.   In this podcast we discuss a recently published article that evaluates clinical exam, radiographic, point-of-care ultrasound, and laboratory findings in the assessment of intravascular volume overload.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/2114/is-this-patient-volume-overloaded.mp3" length="23109863" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Accurate assessment of intravascular volume is critical in managing sick patients in the emergency department or intensive care unit.   In this podcast we discuss a recently published article that evaluates clinical exam, radiographic, point-of-care ultrasound, and laboratory findings in the assessment of intravascular volume overload.]]></itunes:summary>
	<itunes:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2026/03/java.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i1.wp.com/ccpem.blog/wp-content/uploads/2026/03/java.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Is This Patient Volume Overloaded?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:24:04</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Accurate assessment of intravascular volume is critical in managing sick patients in the emergency department or intensive care unit.   In this podcast we discuss a recently published article that evaluates clinical exam, radiographic, point-of-care ultrasound, and laboratory findings in the assessment of intravascular volume overload.]]></googleplay:description>
	<googleplay:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2026/03/java.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>2025: A Year in Review</title>
	<link>https://ccpem.blog/podcast/2025-a-year-in-review/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=2025-a-year-in-review&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=2025-a-year-in-review</link>
	<pubDate>Wed, 25 Feb 2026 13:15:23 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=2109</guid>
	<description><![CDATA[<p>Each year, hundreds of articles are published that pertain to the resuscitation and care of critically ill emergency department patients. In this podcast, we review the key articles from the 2025 emergency medicine, resuscitation, and critical care literature that pertain to the care of critically ill ED patients.</p>]]></description>
	<itunes:subtitle><![CDATA[Each year, hundreds of articles are published that pertain to the resuscitation and care of critically ill emergency department patients. In this podcast, we review the key articles from the 2025 emergency medicine, resuscitation, and critical care liter]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Each year, hundreds of articles are published that pertain to the resuscitation and care of critically ill emergency department patients. In this podcast, we review the key articles from the 2025 emergency medicine, resuscitation, and critical care literature that pertain to the care of critically ill ED patients.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/2109/2025-a-year-in-review.mp3" length="66119719" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Each year, hundreds of articles are published that pertain to the resuscitation and care of critically ill emergency department patients. In this podcast, we review the key articles from the 2025 emergency medicine, resuscitation, and critical care literature that pertain to the care of critically ill ED patients.]]></itunes:summary>
	<itunes:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2026/02/ccpemyir.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i1.wp.com/ccpem.blog/wp-content/uploads/2026/02/ccpemyir.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>2025: A Year in Review</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:55:05</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Each year, hundreds of articles are published that pertain to the resuscitation and care of critically ill emergency department patients. In this podcast, we review the key articles from the 2025 emergency medicine, resuscitation, and critical care literature that pertain to the care of critically ill ED patients.]]></googleplay:description>
	<googleplay:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2026/02/ccpemyir.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Caring for the Patient with ROSC</title>
	<link>https://ccpem.blog/podcast/caring-for-the-patient-with-rosc/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=caring-for-the-patient-with-rosc&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=caring-for-the-patient-with-rosc</link>
	<pubDate>Sat, 22 Nov 2025 14:39:13 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=2104</guid>
	<description><![CDATA[<p>More than 600,000 patients in North America sustain sudden cardiac arrest each year.  When return of spontaneous circulation (ROSC) is achieved, there are a number of critical interventions to consider in order to provide the patient with the best chance of being discharged with meaningful neurologic survival.  In this podcast, we discuss an excellent recent review article on the management of patients with ROSC following cardiac arrest.</p>]]></description>
	<itunes:subtitle><![CDATA[More than 600,000 patients in North America sustain sudden cardiac arrest each year.  When return of spontaneous circulation (ROSC) is achieved, there are a number of critical interventions to consider in order to provide the patient with the best chance]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>More than 600,000 patients in North America sustain sudden cardiac arrest each year.  When return of spontaneous circulation (ROSC) is achieved, there are a number of critical interventions to consider in order to provide the patient with the best chance of being discharged with meaningful neurologic survival.  In this podcast, we discuss an excellent recent review article on the management of patients with ROSC following cardiac arrest.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/2104/caring-for-the-patient-with-rosc.mp3" length="56337962" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[More than 600,000 patients in North America sustain sudden cardiac arrest each year.  When return of spontaneous circulation (ROSC) is achieved, there are a number of critical interventions to consider in order to provide the patient with the best chance of being discharged with meaningful neurologic survival.  In this podcast, we discuss an excellent recent review article on the management of patients with ROSC following cardiac arrest.]]></itunes:summary>
	<itunes:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2025/11/rosc.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i1.wp.com/ccpem.blog/wp-content/uploads/2025/11/rosc.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Caring for the Patient with ROSC</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:46:56</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[More than 600,000 patients in North America sustain sudden cardiac arrest each year.  When return of spontaneous circulation (ROSC) is achieved, there are a number of critical interventions to consider in order to provide the patient with the best chance of being discharged with meaningful neurologic survival.  In this podcast, we discuss an excellent recent review article on the management of patients with ROSC following cardiac arrest.]]></googleplay:description>
	<googleplay:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2025/11/rosc.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Critical Issues in ED Intubation</title>
	<link>https://ccpem.blog/podcast/critical-issues-in-ed-intubation/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=critical-issues-in-ed-intubation&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=critical-issues-in-ed-intubation</link>
	<pubDate>Wed, 15 Oct 2025 15:38:39 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=2099</guid>
	<description><![CDATA[<p>Emergency physicians intubate critically ill patients daily.  Unfortunately, up to 17% of ED intubations can be complicated by peri-intubation hypoxemia, hypotension, and cardiac arrest. Efforts to optimize patient's physiology prior to rapid sequence intubation are critical in mitigating the risk of potentially disastrous peri-intubation complications.  In this podcast, we discuss a recent Clinical Policy from the American College of Emergency Physicians that addresses critical issues in the management of adult ED patients undergoing endotracheal intubation.  </p>]]></description>
	<itunes:subtitle><![CDATA[Emergency physicians intubate critically ill patients daily.  Unfortunately, up to 17% of ED intubations can be complicated by peri-intubation hypoxemia, hypotension, and cardiac arrest. Efforts to optimize patients physiology prior to rapid sequence int]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Emergency physicians intubate critically ill patients daily.  Unfortunately, up to 17% of ED intubations can be complicated by peri-intubation hypoxemia, hypotension, and cardiac arrest. Efforts to optimize patient's physiology prior to rapid sequence intubation are critical in mitigating the risk of potentially disastrous peri-intubation complications.  In this podcast, we discuss a recent Clinical Policy from the American College of Emergency Physicians that addresses critical issues in the management of adult ED patients undergoing endotracheal intubation.  </p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/2099/critical-issues-in-ed-intubation.mp3" length="41270006" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Emergency physicians intubate critically ill patients daily.  Unfortunately, up to 17% of ED intubations can be complicated by peri-intubation hypoxemia, hypotension, and cardiac arrest. Efforts to optimize patient's physiology prior to rapid sequence intubation are critical in mitigating the risk of potentially disastrous peri-intubation complications.  In this podcast, we discuss a recent Clinical Policy from the American College of Emergency Physicians that addresses critical issues in the management of adult ED patients undergoing endotracheal intubation.  ]]></itunes:summary>
	<itunes:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2025/10/intub.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i2.wp.com/ccpem.blog/wp-content/uploads/2025/10/intub.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Critical Issues in ED Intubation</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:34:24</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Emergency physicians intubate critically ill patients daily.  Unfortunately, up to 17% of ED intubations can be complicated by peri-intubation hypoxemia, hypotension, and cardiac arrest. Efforts to optimize patient's physiology prior to rapid sequence intubation are critical in mitigating the risk of potentially disastrous peri-intubation complications.  In this podcast, we discuss a recent Clinical Policy from the American College of Emergency Physicians that addresses critical issues in the management of adult ED patients undergoing endotracheal intubation.  ]]></googleplay:description>
	<googleplay:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2025/10/intub.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Conservative Oxygen Therapy for Ventilated ICU Patients?</title>
	<link>https://ccpem.blog/podcast/conservative-oxygen-therapy-for-ventilated-icu-patients/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=conservative-oxygen-therapy-for-ventilated-icu-patients&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=conservative-oxygen-therapy-for-ventilated-icu-patients</link>
	<pubDate>Fri, 29 Aug 2025 16:51:20 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=2093</guid>
	<description><![CDATA[<p>Oxygen is one of the most used, and misused, therapies delivered to critically ill patients.  In recent years, a number of trials have compared the use of a conservative oxygen therapy strategy with a liberal oxygen therapy strategy.  These trials have produced mixed results and the optimal oxygen strategy for critically ill patients remains unknown.  In this podcast, we discuss the latest study, UK-ROX Trial, to investigate a conservative oxygen therapy strategy with usual oxygen therapy in critically ill ICU patients.  Which approach is better?</p>]]></description>
	<itunes:subtitle><![CDATA[Oxygen is one of the most used, and misused, therapies delivered to critically ill patients.  In recent years, a number of trials have compared the use of a conservative oxygen therapy strategy with a liberal oxygen therapy strategy.  These trials have p]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Oxygen is one of the most used, and misused, therapies delivered to critically ill patients.  In recent years, a number of trials have compared the use of a conservative oxygen therapy strategy with a liberal oxygen therapy strategy.  These trials have produced mixed results and the optimal oxygen strategy for critically ill patients remains unknown.  In this podcast, we discuss the latest study, UK-ROX Trial, to investigate a conservative oxygen therapy strategy with usual oxygen therapy in critically ill ICU patients.  Which approach is better?</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/2093/conservative-oxygen-therapy-for-ventilated-icu-patients.mp3" length="24847290" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Oxygen is one of the most used, and misused, therapies delivered to critically ill patients.  In recent years, a number of trials have compared the use of a conservative oxygen therapy strategy with a liberal oxygen therapy strategy.  These trials have produced mixed results and the optimal oxygen strategy for critically ill patients remains unknown.  In this podcast, we discuss the latest study, UK-ROX Trial, to investigate a conservative oxygen therapy strategy with usual oxygen therapy in critically ill ICU patients.  Which approach is better?]]></itunes:summary>
	<itunes:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2025/08/rox.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i1.wp.com/ccpem.blog/wp-content/uploads/2025/08/rox.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Conservative Oxygen Therapy for Ventilated ICU Patients?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:20:42</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Oxygen is one of the most used, and misused, therapies delivered to critically ill patients.  In recent years, a number of trials have compared the use of a conservative oxygen therapy strategy with a liberal oxygen therapy strategy.  These trials have produced mixed results and the optimal oxygen strategy for critically ill patients remains unknown.  In this podcast, we discuss the latest study, UK-ROX Trial, to investigate a conservative oxygen therapy strategy with usual oxygen therapy in critically ill ICU patients.  Which approach is better?]]></googleplay:description>
	<googleplay:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2025/08/rox.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Dexmedetomidine or Propofol for Sedation in the Critically Ill?</title>
	<link>https://ccpem.blog/podcast/dexmedetomidine-or-propofol-for-sedation-in-the-critically-ill/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=dexmedetomidine-or-propofol-for-sedation-in-the-critically-ill&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=dexmedetomidine-or-propofol-for-sedation-in-the-critically-ill</link>
	<pubDate>Mon, 07 Jul 2025 13:55:51 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=2086</guid>
	<description><![CDATA[<p>Critically ill patients receiving mechanical ventilation require analgesia and sedation.&nbsp; At present, propofol remains the most widely used sedative for intubated/ventilated patients.&nbsp; Recent trials have suggested that dexmedetomidine may reduce delirium and the duration of mechanical ventilation compared with other sedative medications.&nbsp; In fact, recent SCCM guidelines suggest the use of dexmedetomidine over propofol in intubated patients.&nbsp; In this podcast, we discuss a recent randomized trial that compared the effectiveness and safety of a dexmedetomidine-based sedation strategy with a propofol-based sedation strategy in mechanically ventilated critically ill patients.</p>]]></description>
	<itunes:subtitle><![CDATA[Critically ill patients receiving mechanical ventilation require analgesia and sedation.&nbsp; At present, propofol remains the most widely used sedative for intubated/ventilated patients.&nbsp; Recent trials have suggested that dexmedetomidine may reduc]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Critically ill patients receiving mechanical ventilation require analgesia and sedation.&nbsp; At present, propofol remains the most widely used sedative for intubated/ventilated patients.&nbsp; Recent trials have suggested that dexmedetomidine may reduce delirium and the duration of mechanical ventilation compared with other sedative medications.&nbsp; In fact, recent SCCM guidelines suggest the use of dexmedetomidine over propofol in intubated patients.&nbsp; In this podcast, we discuss a recent randomized trial that compared the effectiveness and safety of a dexmedetomidine-based sedation strategy with a propofol-based sedation strategy in mechanically ventilated critically ill patients.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/2086/dexmedetomidine-or-propofol-for-sedation-in-the-critically-ill.mp3" length="26295507" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Critically ill patients receiving mechanical ventilation require analgesia and sedation.&nbsp; At present, propofol remains the most widely used sedative for intubated/ventilated patients.&nbsp; Recent trials have suggested that dexmedetomidine may reduce delirium and the duration of mechanical ventilation compared with other sedative medications.&nbsp; In fact, recent SCCM guidelines suggest the use of dexmedetomidine over propofol in intubated patients.&nbsp; In this podcast, we discuss a recent randomized trial that compared the effectiveness and safety of a dexmedetomidine-based sedation strategy with a propofol-based sedation strategy in mechanically ventilated critically ill patients.]]></itunes:summary>
	<itunes:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2025/07/a2b.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i2.wp.com/ccpem.blog/wp-content/uploads/2025/07/a2b.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Dexmedetomidine or Propofol for Sedation in the Critically Ill?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:21:54</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Critically ill patients receiving mechanical ventilation require analgesia and sedation.&nbsp; At present, propofol remains the most widely used sedative for intubated/ventilated patients.&nbsp; Recent trials have suggested that dexmedetomidine may reduce delirium and the duration of mechanical ventilation compared with other sedative medications.&nbsp; In fact, recent SCCM guidelines suggest the use of dexmedetomidine over propofol in intubated patients.&nbsp; In this podcast, we discuss a recent randomized trial that compared the effectiveness and safety of a dexmedetomidine-based sedation strategy with a propofol-based sedation strategy in mechanically ventilated critically ill patients.]]></googleplay:description>
	<googleplay:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2025/07/a2b.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Palliative Care in the ED</title>
	<link>https://ccpem.blog/podcast/palliative-care-in-the-ed/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=palliative-care-in-the-ed&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=palliative-care-in-the-ed</link>
	<pubDate>Sat, 17 May 2025 19:46:38 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=2081</guid>
	<description><![CDATA[<p>Approximately 75% of patients older than 65 years of age are seen in an ED within 6 months of their death.  While palliative care teams are now present in many hospitals in the US, they are often not present 24/7 or in resource-limited settings.  As such, there may be an opportunity to improve palliative care in the ED by providing palliative care education to ED team members.  In this podcast, we review the recently published PRIM-ER trial, which evaluated the impact of a robust primary palliative care intervention on hospital admission rates in 29 EDs across the US.</p>]]></description>
	<itunes:subtitle><![CDATA[Approximately 75% of patients older than 65 years of age are seen in an ED within 6 months of their death.  While palliative care teams are now present in many hospitals in the US, they are often not present 24/7 or in resource-limited settings.  As such]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Approximately 75% of patients older than 65 years of age are seen in an ED within 6 months of their death.  While palliative care teams are now present in many hospitals in the US, they are often not present 24/7 or in resource-limited settings.  As such, there may be an opportunity to improve palliative care in the ED by providing palliative care education to ED team members.  In this podcast, we review the recently published PRIM-ER trial, which evaluated the impact of a robust primary palliative care intervention on hospital admission rates in 29 EDs across the US.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/2081/palliative-care-in-the-ed.mp3" length="31236383" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Approximately 75% of patients older than 65 years of age are seen in an ED within 6 months of their death.  While palliative care teams are now present in many hospitals in the US, they are often not present 24/7 or in resource-limited settings.  As such, there may be an opportunity to improve palliative care in the ED by providing palliative care education to ED team members.  In this podcast, we review the recently published PRIM-ER trial, which evaluated the impact of a robust primary palliative care intervention on hospital admission rates in 29 EDs across the US.]]></itunes:summary>
	<itunes:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2025/05/pall.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i0.wp.com/ccpem.blog/wp-content/uploads/2025/05/pall.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Palliative Care in the ED</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:26:02</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Approximately 75% of patients older than 65 years of age are seen in an ED within 6 months of their death.  While palliative care teams are now present in many hospitals in the US, they are often not present 24/7 or in resource-limited settings.  As such, there may be an opportunity to improve palliative care in the ED by providing palliative care education to ED team members.  In this podcast, we review the recently published PRIM-ER trial, which evaluated the impact of a robust primary palliative care intervention on hospital admission rates in 29 EDs across the US.]]></googleplay:description>
	<googleplay:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2025/05/pall.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>When Should We Start Vasopressin in Septic Shock?</title>
	<link>https://ccpem.blog/podcast/when-should-we-start-vasopressin-in-septic-shock/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=when-should-we-start-vasopressin-in-septic-shock&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=when-should-we-start-vasopressin-in-septic-shock</link>
	<pubDate>Tue, 15 Apr 2025 16:52:49 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=2076</guid>
	<description><![CDATA[<p>Sepsis results in more than 250,000 deaths each year in the United States. Resuscitation of the septic patient centers on timely recognition, early antibiotic administration, appropriate fluid administration, source control, and vasopressor administration for those with inadequate mean arterial pressures. At present, norepinephrine is the recommended first-line vasopressor for sepsis.&nbsp; Current guidelines then recommend vasopressin as the second-line vasopressor agent, but the optimal timing of its initiation remains unknown. In this podcast, we discuss a recent article on the use of a machine learning tool for vasopressin administration to optimize short- and long-term outcomes in patients with sepsis.</p>]]></description>
	<itunes:subtitle><![CDATA[Sepsis results in more than 250,000 deaths each year in the United States. Resuscitation of the septic patient centers on timely recognition, early antibiotic administration, appropriate fluid administration, source control, and vasopressor administratio]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Sepsis results in more than 250,000 deaths each year in the United States. Resuscitation of the septic patient centers on timely recognition, early antibiotic administration, appropriate fluid administration, source control, and vasopressor administration for those with inadequate mean arterial pressures. At present, norepinephrine is the recommended first-line vasopressor for sepsis.&nbsp; Current guidelines then recommend vasopressin as the second-line vasopressor agent, but the optimal timing of its initiation remains unknown. In this podcast, we discuss a recent article on the use of a machine learning tool for vasopressin administration to optimize short- and long-term outcomes in patients with sepsis.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/2076/when-should-we-start-vasopressin-in-septic-shock.mp3" length="30624132" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Sepsis results in more than 250,000 deaths each year in the United States. Resuscitation of the septic patient centers on timely recognition, early antibiotic administration, appropriate fluid administration, source control, and vasopressor administration for those with inadequate mean arterial pressures. At present, norepinephrine is the recommended first-line vasopressor for sepsis.&nbsp; Current guidelines then recommend vasopressin as the second-line vasopressor agent, but the optimal timing of its initiation remains unknown. In this podcast, we discuss a recent article on the use of a machine learning tool for vasopressin administration to optimize short- and long-term outcomes in patients with sepsis.]]></itunes:summary>
	<itunes:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2025/04/vaso2025.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i2.wp.com/ccpem.blog/wp-content/uploads/2025/04/vaso2025.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>When Should We Start Vasopressin in Septic Shock?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:25:31</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Sepsis results in more than 250,000 deaths each year in the United States. Resuscitation of the septic patient centers on timely recognition, early antibiotic administration, appropriate fluid administration, source control, and vasopressor administration for those with inadequate mean arterial pressures. At present, norepinephrine is the recommended first-line vasopressor for sepsis.&nbsp; Current guidelines then recommend vasopressin as the second-line vasopressor agent, but the optimal timing of its initiation remains unknown. In this podcast, we discuss a recent article on the use of a machine learning tool for vasopressin administration to optimize short- and long-term outcomes in patients with sepsis.]]></googleplay:description>
	<googleplay:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2025/04/vaso2025.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>IV or IO Vascular Access for OHCA?</title>
	<link>https://ccpem.blog/podcast/iv-or-io-vascular-access-for-ohca/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=iv-or-io-vascular-access-for-ohca&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=iv-or-io-vascular-access-for-ohca</link>
	<pubDate>Mon, 24 Feb 2025 14:32:31 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=2071</guid>
	<description><![CDATA[<p>Nearly 4 million patients sustain out-of-hospital cardiac arrest (OHCA) worldwide each year.  International guidelines for the resuscitation of patients with OHCA recommend early administration of epinephrine in those with an initial nonshockable rhythm.  Both intravenous (IV) and intraosseous (IO) access are routinely attempted to gain vascular access to administer medications.  While IV access is recommended, this is based on very low certainty evidence.  In this podcast, we discuss three recently published randomized trials that investigated IO and IV access in patients with OHCA.</p>]]></description>
	<itunes:subtitle><![CDATA[Nearly 4 million patients sustain out-of-hospital cardiac arrest (OHCA) worldwide each year.  International guidelines for the resuscitation of patients with OHCA recommend early administration of epinephrine in those with an initial nonshockable rhythm.]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Nearly 4 million patients sustain out-of-hospital cardiac arrest (OHCA) worldwide each year.  International guidelines for the resuscitation of patients with OHCA recommend early administration of epinephrine in those with an initial nonshockable rhythm.  Both intravenous (IV) and intraosseous (IO) access are routinely attempted to gain vascular access to administer medications.  While IV access is recommended, this is based on very low certainty evidence.  In this podcast, we discuss three recently published randomized trials that investigated IO and IV access in patients with OHCA.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/2071/iv-or-io-vascular-access-for-ohca.mp3" length="31379008" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Nearly 4 million patients sustain out-of-hospital cardiac arrest (OHCA) worldwide each year.  International guidelines for the resuscitation of patients with OHCA recommend early administration of epinephrine in those with an initial nonshockable rhythm.  Both intravenous (IV) and intraosseous (IO) access are routinely attempted to gain vascular access to administer medications.  While IV access is recommended, this is based on very low certainty evidence.  In this podcast, we discuss three recently published randomized trials that investigated IO and IV access in patients with OHCA.]]></itunes:summary>
	<itunes:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2025/02/ohca.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i2.wp.com/ccpem.blog/wp-content/uploads/2025/02/ohca.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>IV or IO Vascular Access for OHCA?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:26:09</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Nearly 4 million patients sustain out-of-hospital cardiac arrest (OHCA) worldwide each year.  International guidelines for the resuscitation of patients with OHCA recommend early administration of epinephrine in those with an initial nonshockable rhythm.  Both intravenous (IV) and intraosseous (IO) access are routinely attempted to gain vascular access to administer medications.  While IV access is recommended, this is based on very low certainty evidence.  In this podcast, we discuss three recently published randomized trials that investigated IO and IV access in patients with OHCA.]]></googleplay:description>
	<googleplay:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2025/02/ohca.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Is HFNC noninferior to NIV for Acute Respiratory Failure?</title>
	<link>https://ccpem.blog/podcast/is-hfnc-noninferior-to-niv-for-acute-respiratory-failure/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=is-hfnc-noninferior-to-niv-for-acute-respiratory-failure&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=is-hfnc-noninferior-to-niv-for-acute-respiratory-failure</link>
	<pubDate>Fri, 24 Jan 2025 15:43:55 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=2066</guid>
	<description><![CDATA[<p>Both NIV and HFNC are used to treat patients with acute respiratory failure.  Current guidelines recommend NIV for acute respiratory failure caused by COPD and acute cardiogenic pulmonary edema.  However, NIV may be hard for some patients to tolerate. When compared to low-flow oxygen therapy, HFNC has been shown to improve oxygenation, improve alveolar recruitment, and enhance clearance of secretions. HFNC may be easier to use and tolerate than NIV, but there remains uncertainty regarding the effectiveness of HFNC compared to NIV for acute hypoxemic respiratory failure. In this podcast, we discuss the RENOVATE trial that sought to compare HFNC with NIV on rates of intubation in patients with acute respiratory failure.</p>]]></description>
	<itunes:subtitle><![CDATA[Both NIV and HFNC are used to treat patients with acute respiratory failure.  Current guidelines recommend NIV for acute respiratory failure caused by COPD and acute cardiogenic pulmonary edema.  However, NIV may be hard for some patients to tolerate. Wh]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Both NIV and HFNC are used to treat patients with acute respiratory failure.  Current guidelines recommend NIV for acute respiratory failure caused by COPD and acute cardiogenic pulmonary edema.  However, NIV may be hard for some patients to tolerate. When compared to low-flow oxygen therapy, HFNC has been shown to improve oxygenation, improve alveolar recruitment, and enhance clearance of secretions. HFNC may be easier to use and tolerate than NIV, but there remains uncertainty regarding the effectiveness of HFNC compared to NIV for acute hypoxemic respiratory failure. In this podcast, we discuss the RENOVATE trial that sought to compare HFNC with NIV on rates of intubation in patients with acute respiratory failure.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/2066/is-hfnc-noninferior-to-niv-for-acute-respiratory-failure.mp3" length="38084754" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Both NIV and HFNC are used to treat patients with acute respiratory failure.  Current guidelines recommend NIV for acute respiratory failure caused by COPD and acute cardiogenic pulmonary edema.  However, NIV may be hard for some patients to tolerate. When compared to low-flow oxygen therapy, HFNC has been shown to improve oxygenation, improve alveolar recruitment, and enhance clearance of secretions. HFNC may be easier to use and tolerate than NIV, but there remains uncertainty regarding the effectiveness of HFNC compared to NIV for acute hypoxemic respiratory failure. In this podcast, we discuss the RENOVATE trial that sought to compare HFNC with NIV on rates of intubation in patients with acute respiratory failure.]]></itunes:summary>
	<itunes:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2025/01/renovatetrial.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i0.wp.com/ccpem.blog/wp-content/uploads/2025/01/renovatetrial.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Is HFNC noninferior to NIV for Acute Respiratory Failure?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:31:44</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Both NIV and HFNC are used to treat patients with acute respiratory failure.  Current guidelines recommend NIV for acute respiratory failure caused by COPD and acute cardiogenic pulmonary edema.  However, NIV may be hard for some patients to tolerate. When compared to low-flow oxygen therapy, HFNC has been shown to improve oxygenation, improve alveolar recruitment, and enhance clearance of secretions. HFNC may be easier to use and tolerate than NIV, but there remains uncertainty regarding the effectiveness of HFNC compared to NIV for acute hypoxemic respiratory failure. In this podcast, we discuss the RENOVATE trial that sought to compare HFNC with NIV on rates of intubation in patients with acute respiratory failure.]]></googleplay:description>
	<googleplay:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2025/01/renovatetrial.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>High-Intensity NIPPV for Acute COPD Exacerbations?</title>
	<link>https://ccpem.blog/podcast/high-intensity-nippv-for-acute-copd-exacerbations/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=high-intensity-nippv-for-acute-copd-exacerbations&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=high-intensity-nippv-for-acute-copd-exacerbations</link>
	<pubDate>Thu, 05 Dec 2024 15:24:04 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=2061</guid>
	<description><![CDATA[<p>NIPPV is frequently used in the management of critically ill patients presenting with an acute COPD exacerbation, as NIPPV decreases the rates of intubation and is associated with lower in-hospital mortality.  Typically, "low" intensity NIPPV, whereby inspiratory positive airway pressures less than 18 cm H2O are used. More recently, the use of "high" intensity NIPPV, with IPAPs between 20-30 cm H2O, has been shown to improve gas exchange, ventilatory function, and improve arterial PCO2 values.  In this podcast, we review the HAPPEN Trial, which compared low intensity to high intensity NIPPV on the need for intubation in patients with an acute COPD exacerbation and hypercapnia.</p>]]></description>
	<itunes:subtitle><![CDATA[NIPPV is frequently used in the management of critically ill patients presenting with an acute COPD exacerbation, as NIPPV decreases the rates of intubation and is associated with lower in-hospital mortality.  Typically, low intensity NIPPV, whereby insp]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>NIPPV is frequently used in the management of critically ill patients presenting with an acute COPD exacerbation, as NIPPV decreases the rates of intubation and is associated with lower in-hospital mortality.  Typically, "low" intensity NIPPV, whereby inspiratory positive airway pressures less than 18 cm H2O are used. More recently, the use of "high" intensity NIPPV, with IPAPs between 20-30 cm H2O, has been shown to improve gas exchange, ventilatory function, and improve arterial PCO2 values.  In this podcast, we review the HAPPEN Trial, which compared low intensity to high intensity NIPPV on the need for intubation in patients with an acute COPD exacerbation and hypercapnia.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/2061/high-intensity-nippv-for-acute-copd-exacerbations.mp3" length="30939106" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[NIPPV is frequently used in the management of critically ill patients presenting with an acute COPD exacerbation, as NIPPV decreases the rates of intubation and is associated with lower in-hospital mortality.  Typically, "low" intensity NIPPV, whereby inspiratory positive airway pressures less than 18 cm H2O are used. More recently, the use of "high" intensity NIPPV, with IPAPs between 20-30 cm H2O, has been shown to improve gas exchange, ventilatory function, and improve arterial PCO2 values.  In this podcast, we review the HAPPEN Trial, which compared low intensity to high intensity NIPPV on the need for intubation in patients with an acute COPD exacerbation and hypercapnia.]]></itunes:summary>
	<itunes:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2024/12/happen.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i1.wp.com/ccpem.blog/wp-content/uploads/2024/12/happen.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>High-Intensity NIPPV for Acute COPD Exacerbations?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:25:46</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[NIPPV is frequently used in the management of critically ill patients presenting with an acute COPD exacerbation, as NIPPV decreases the rates of intubation and is associated with lower in-hospital mortality.  Typically, "low" intensity NIPPV, whereby inspiratory positive airway pressures less than 18 cm H2O are used. More recently, the use of "high" intensity NIPPV, with IPAPs between 20-30 cm H2O, has been shown to improve gas exchange, ventilatory function, and improve arterial PCO2 values.  In this podcast, we review the HAPPEN Trial, which compared low intensity to high intensity NIPPV on the need for intubation in patients with an acute COPD exacerbation and hypercapnia.]]></googleplay:description>
	<googleplay:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2024/12/happen.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Naloxone for OHCA?</title>
	<link>https://ccpem.blog/podcast/naloxone-for-ohca/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=naloxone-for-ohca&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=naloxone-for-ohca</link>
	<pubDate>Fri, 01 Nov 2024 17:05:11 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=2056</guid>
	<description><![CDATA[<p>The incidence of opioid-associated out-of-hospital cardiac arrests continues to rise.  Current guidelines for the resuscitation of patients with OHCA advise the clinician to consider the administration of naloxone of patients with suspected opioid-associated OHCA.  In this podcast, we review a recenlty published study in JAMA that evaluated the association of naloxone with patient outcomes in opioid-associated OHCAs.</p>]]></description>
	<itunes:subtitle><![CDATA[The incidence of opioid-associated out-of-hospital cardiac arrests continues to rise.  Current guidelines for the resuscitation of patients with OHCA advise the clinician to consider the administration of naloxone of patients with suspected opioid-associ]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>The incidence of opioid-associated out-of-hospital cardiac arrests continues to rise.  Current guidelines for the resuscitation of patients with OHCA advise the clinician to consider the administration of naloxone of patients with suspected opioid-associated OHCA.  In this podcast, we review a recenlty published study in JAMA that evaluated the association of naloxone with patient outcomes in opioid-associated OHCAs.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/2056/naloxone-for-ohca.mp3" length="26848799" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[The incidence of opioid-associated out-of-hospital cardiac arrests continues to rise.  Current guidelines for the resuscitation of patients with OHCA advise the clinician to consider the administration of naloxone of patients with suspected opioid-associated OHCA.  In this podcast, we review a recenlty published study in JAMA that evaluated the association of naloxone with patient outcomes in opioid-associated OHCAs.]]></itunes:summary>
	<itunes:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2024/11/naxalone.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i0.wp.com/ccpem.blog/wp-content/uploads/2024/11/naxalone.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Naloxone for OHCA?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:22:22</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[The incidence of opioid-associated out-of-hospital cardiac arrests continues to rise.  Current guidelines for the resuscitation of patients with OHCA advise the clinician to consider the administration of naloxone of patients with suspected opioid-associated OHCA.  In this podcast, we review a recenlty published study in JAMA that evaluated the association of naloxone with patient outcomes in opioid-associated OHCAs.]]></googleplay:description>
	<googleplay:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2024/11/naxalone.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Continuous or Intermittent B-Lactam Infusions for Sepsis?</title>
	<link>https://ccpem.blog/podcast/continuous-or-intermittent-b-lactam-infusions-for-sepsis/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=continuous-or-intermittent-b-lactam-infusions-for-sepsis&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=continuous-or-intermittent-b-lactam-infusions-for-sepsis</link>
	<pubDate>Tue, 24 Sep 2024 18:55:47 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=2048</guid>
	<description><![CDATA[<p>Timely administration of broad-spectrum antibiotics is a critical pillar in the resuscitation of patients with sepsis.  B-lactam antibiotics are an important class of antibiotics commonly administered to patients with sepsis.  Typically, B-lactam antibiotics are administered over 30 minutes, but optimal bactericidal activity requires the concentration of free drug to be above the MIC of the organism for 40-70% of the dosing interval.  In this podcast we discuss two recent publications that compare continuous infusions of B-lactam antibiotics with intermittent effusions in patients with sepsis.  </p>]]></description>
	<itunes:subtitle><![CDATA[Timely administration of broad-spectrum antibiotics is a critical pillar in the resuscitation of patients with sepsis.  B-lactam antibiotics are an important class of antibiotics commonly administered to patients with sepsis.  Typically, B-lactam antibio]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Timely administration of broad-spectrum antibiotics is a critical pillar in the resuscitation of patients with sepsis.  B-lactam antibiotics are an important class of antibiotics commonly administered to patients with sepsis.  Typically, B-lactam antibiotics are administered over 30 minutes, but optimal bactericidal activity requires the concentration of free drug to be above the MIC of the organism for 40-70% of the dosing interval.  In this podcast we discuss two recent publications that compare continuous infusions of B-lactam antibiotics with intermittent effusions in patients with sepsis.  </p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/2048/continuous-or-intermittent-b-lactam-infusions-for-sepsis.mp3" length="36029491" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Timely administration of broad-spectrum antibiotics is a critical pillar in the resuscitation of patients with sepsis.  B-lactam antibiotics are an important class of antibiotics commonly administered to patients with sepsis.  Typically, B-lactam antibiotics are administered over 30 minutes, but optimal bactericidal activity requires the concentration of free drug to be above the MIC of the organism for 40-70% of the dosing interval.  In this podcast we discuss two recent publications that compare continuous infusions of B-lactam antibiotics with intermittent effusions in patients with sepsis.]]></itunes:summary>
	<itunes:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2024/09/sepsis.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i0.wp.com/ccpem.blog/wp-content/uploads/2024/09/sepsis.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Continuous or Intermittent B-Lactam Infusions for Sepsis?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:29:51</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Timely administration of broad-spectrum antibiotics is a critical pillar in the resuscitation of patients with sepsis.  B-lactam antibiotics are an important class of antibiotics commonly administered to patients with sepsis.  Typically, B-lactam antibiotics are administered over 30 minutes, but optimal bactericidal activity requires the concentration of free drug to be above the MIC of the organism for 40-70% of the dosing interval.  In this podcast we discuss two recent publications that compare continuous infusions of B-lactam antibiotics with intermittent effusions in patients with sepsis.]]></googleplay:description>
	<googleplay:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2024/09/sepsis.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>What Oxygenation Strategy Should We Use for COVID-19 Patients?</title>
	<link>https://ccpem.blog/podcast/what-oxygenation-strategy-should-we-use-for-covid-19-patients/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=what-oxygenation-strategy-should-we-use-for-covid-19-patients&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=what-oxygenation-strategy-should-we-use-for-covid-19-patients</link>
	<pubDate>Sat, 27 Jul 2024 01:22:54 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=2043</guid>
	<description><![CDATA[<p>Patients with COVID-19 can require supplemental oxygen for acute hypoxemic respiratory failure.  While international guidelines recommend a target SpO2 between 90-96%, a safe oxygenation strategy has not been identified.  In this podcast, we discuss the recently published HOT-COVID Trial, which compared a lower oxygenation strategy with a higher oxygenation strategy in adult ICU patients with COVID-19.</p>]]></description>
	<itunes:subtitle><![CDATA[Patients with COVID-19 can require supplemental oxygen for acute hypoxemic respiratory failure.  While international guidelines recommend a target SpO2 between 90-96%, a safe oxygenation strategy has not been identified.  In this podcast, we discuss the ]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Patients with COVID-19 can require supplemental oxygen for acute hypoxemic respiratory failure.  While international guidelines recommend a target SpO2 between 90-96%, a safe oxygenation strategy has not been identified.  In this podcast, we discuss the recently published HOT-COVID Trial, which compared a lower oxygenation strategy with a higher oxygenation strategy in adult ICU patients with COVID-19.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/2043/what-oxygenation-strategy-should-we-use-for-covid-19-patients.mp3" length="29343303" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Patients with COVID-19 can require supplemental oxygen for acute hypoxemic respiratory failure.  While international guidelines recommend a target SpO2 between 90-96%, a safe oxygenation strategy has not been identified.  In this podcast, we discuss the recently published HOT-COVID Trial, which compared a lower oxygenation strategy with a higher oxygenation strategy in adult ICU patients with COVID-19.]]></itunes:summary>
	<itunes:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2024/07/hotcovid.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i2.wp.com/ccpem.blog/wp-content/uploads/2024/07/hotcovid.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>What Oxygenation Strategy Should We Use for COVID-19 Patients?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:20:23</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Patients with COVID-19 can require supplemental oxygen for acute hypoxemic respiratory failure.  While international guidelines recommend a target SpO2 between 90-96%, a safe oxygenation strategy has not been identified.  In this podcast, we discuss the recently published HOT-COVID Trial, which compared a lower oxygenation strategy with a higher oxygenation strategy in adult ICU patients with COVID-19.]]></googleplay:description>
	<googleplay:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2024/07/hotcovid.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Should We Use NIPPV for Preoxygenation for All Intubations?</title>
	<link>https://ccpem.blog/podcast/should-we-use-nippv-for-preoxygenation-for-all-intubations/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=should-we-use-nippv-for-preoxygenation-for-all-intubations&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=should-we-use-nippv-for-preoxygenation-for-all-intubations</link>
	<pubDate>Tue, 09 Jul 2024 11:27:31 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=2038</guid>
	<description><![CDATA[<p>Over 1 million critically ill patients are intubated each year in the US.&nbsp; Hypoxemia occurs in up to 20% of patients and can lead to peri-intubation cardiovascular collapse and cardiac arrest.&nbsp; As such, adequate and appropriate preoxygenation is critical in increasing the safe apnea time and decreasing the risk of hypoxemia.&nbsp; At present, the majority of patients receive preoxygenation through a non-rebreather mask.&nbsp; In this podcast, we discuss a recent study that evaluated the use of noninvasive ventilation for preoxygenation in critically ill patients.</p>]]></description>
	<itunes:subtitle><![CDATA[Over 1 million critically ill patients are intubated each year in the US.&nbsp; Hypoxemia occurs in up to 20% of patients and can lead to peri-intubation cardiovascular collapse and cardiac arrest.&nbsp; As such, adequate and appropriate preoxygenation i]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Over 1 million critically ill patients are intubated each year in the US.&nbsp; Hypoxemia occurs in up to 20% of patients and can lead to peri-intubation cardiovascular collapse and cardiac arrest.&nbsp; As such, adequate and appropriate preoxygenation is critical in increasing the safe apnea time and decreasing the risk of hypoxemia.&nbsp; At present, the majority of patients receive preoxygenation through a non-rebreather mask.&nbsp; In this podcast, we discuss a recent study that evaluated the use of noninvasive ventilation for preoxygenation in critically ill patients.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/2038/should-we-use-nippv-for-preoxygenation-for-all-intubations.mp3" length="38104361" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Over 1 million critically ill patients are intubated each year in the US.&nbsp; Hypoxemia occurs in up to 20% of patients and can lead to peri-intubation cardiovascular collapse and cardiac arrest.&nbsp; As such, adequate and appropriate preoxygenation is critical in increasing the safe apnea time and decreasing the risk of hypoxemia.&nbsp; At present, the majority of patients receive preoxygenation through a non-rebreather mask.&nbsp; In this podcast, we discuss a recent study that evaluated the use of noninvasive ventilation for preoxygenation in critically ill patients.]]></itunes:summary>
	<itunes:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2024/07/nippv.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i1.wp.com/ccpem.blog/wp-content/uploads/2024/07/nippv.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Should We Use NIPPV for Preoxygenation for All Intubations?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:26:28</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Over 1 million critically ill patients are intubated each year in the US.&nbsp; Hypoxemia occurs in up to 20% of patients and can lead to peri-intubation cardiovascular collapse and cardiac arrest.&nbsp; As such, adequate and appropriate preoxygenation is critical in increasing the safe apnea time and decreasing the risk of hypoxemia.&nbsp; At present, the majority of patients receive preoxygenation through a non-rebreather mask.&nbsp; In this podcast, we discuss a recent study that evaluated the use of noninvasive ventilation for preoxygenation in critically ill patients.]]></googleplay:description>
	<googleplay:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2024/07/nippv.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Cefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial</title>
	<link>https://ccpem.blog/podcast/cefepime-vs-piperacillin-tazobactam-for-infection-the-acorn-trial/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=cefepime-vs-piperacillin-tazobactam-for-infection-the-acorn-trial&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=cefepime-vs-piperacillin-tazobactam-for-infection-the-acorn-trial</link>
	<pubDate>Fri, 07 Jun 2024 20:19:33 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=2033</guid>
	<description><![CDATA[<p>Timely and appropriate administration of empiric broad-spectrum antibiotics for adult patients with sepsis is critical.  Current guidelines recommend an antipseudomonal antibiotic for those at risk of a resistant gram-negative organism.  The two most common antipseudomonal antibiotics prescribed in this setting are cefepime and piperacillin-tazobactam.  In recent years, observational studies have reported an association with cefepime and neurotoxicity, whereas piperacillin-tazobactam has been associated with AKI especially when given with vancomycin.  In this podcast, we discuss the recently published ACORN Trial, a randomized trial that evaluated cefepime and piperacillin-tazobactam for adult patients with suspected infection.</p>]]></description>
	<itunes:subtitle><![CDATA[Timely and appropriate administration of empiric broad-spectrum antibiotics for adult patients with sepsis is critical.  Current guidelines recommend an antipseudomonal antibiotic for those at risk of a resistant gram-negative organism.  The two most com]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Timely and appropriate administration of empiric broad-spectrum antibiotics for adult patients with sepsis is critical.  Current guidelines recommend an antipseudomonal antibiotic for those at risk of a resistant gram-negative organism.  The two most common antipseudomonal antibiotics prescribed in this setting are cefepime and piperacillin-tazobactam.  In recent years, observational studies have reported an association with cefepime and neurotoxicity, whereas piperacillin-tazobactam has been associated with AKI especially when given with vancomycin.  In this podcast, we discuss the recently published ACORN Trial, a randomized trial that evaluated cefepime and piperacillin-tazobactam for adult patients with suspected infection.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/2033/cefepime-vs-piperacillin-tazobactam-for-infection-the-acorn-trial.mp3" length="32256269" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Timely and appropriate administration of empiric broad-spectrum antibiotics for adult patients with sepsis is critical.  Current guidelines recommend an antipseudomonal antibiotic for those at risk of a resistant gram-negative organism.  The two most common antipseudomonal antibiotics prescribed in this setting are cefepime and piperacillin-tazobactam.  In recent years, observational studies have reported an association with cefepime and neurotoxicity, whereas piperacillin-tazobactam has been associated with AKI especially when given with vancomycin.  In this podcast, we discuss the recently published ACORN Trial, a randomized trial that evaluated cefepime and piperacillin-tazobactam for adult patients with suspected infection.]]></itunes:summary>
	<itunes:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2024/06/acord.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i2.wp.com/ccpem.blog/wp-content/uploads/2024/06/acord.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Cefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:22:24</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Timely and appropriate administration of empiric broad-spectrum antibiotics for adult patients with sepsis is critical.  Current guidelines recommend an antipseudomonal antibiotic for those at risk of a resistant gram-negative organism.  The two most common antipseudomonal antibiotics prescribed in this setting are cefepime and piperacillin-tazobactam.  In recent years, observational studies have reported an association with cefepime and neurotoxicity, whereas piperacillin-tazobactam has been associated with AKI especially when given with vancomycin.  In this podcast, we discuss the recently published ACORN Trial, a randomized trial that evaluated cefepime and piperacillin-tazobactam for adult patients with suspected infection.]]></googleplay:description>
	<googleplay:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2024/06/acord.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Are We Ventilating our OHCA Patients?</title>
	<link>https://ccpem.blog/podcast/are-we-ventilating-our-ohca-patients/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=are-we-ventilating-our-ohca-patients&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=are-we-ventilating-our-ohca-patients</link>
	<pubDate>Wed, 24 Apr 2024 16:16:06 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=2027</guid>
	<description><![CDATA[<p>In recent years, there has been intense focus on delivering high-quality compressions during the resuscitation of patients with OHCA.  In contrast, ventilation metrics in OHCA resuscitation have not been well studied.  In this podcast, we discuss a recent publication from Circulation that evaluated ventilation waveforms during OHCA resuscitation and the association of these metrics on patient outcomes.  Can we do better?</p>]]></description>
	<itunes:subtitle><![CDATA[In recent years, there has been intense focus on delivering high-quality compressions during the resuscitation of patients with OHCA.  In contrast, ventilation metrics in OHCA resuscitation have not been well studied.  In this podcast, we discuss a recen]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>In recent years, there has been intense focus on delivering high-quality compressions during the resuscitation of patients with OHCA.  In contrast, ventilation metrics in OHCA resuscitation have not been well studied.  In this podcast, we discuss a recent publication from Circulation that evaluated ventilation waveforms during OHCA resuscitation and the association of these metrics on patient outcomes.  Can we do better?</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/2027/are-we-ventilating-our-ohca-patients.mp3" length="26963439" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[In recent years, there has been intense focus on delivering high-quality compressions during the resuscitation of patients with OHCA.  In contrast, ventilation metrics in OHCA resuscitation have not been well studied.  In this podcast, we discuss a recent publication from Circulation that evaluated ventilation waveforms during OHCA resuscitation and the association of these metrics on patient outcomes.  Can we do better?]]></itunes:summary>
	<itunes:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2024/04/ohca.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i0.wp.com/ccpem.blog/wp-content/uploads/2024/04/ohca.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Are We Ventilating our OHCA Patients?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:18:44</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[In recent years, there has been intense focus on delivering high-quality compressions during the resuscitation of patients with OHCA.  In contrast, ventilation metrics in OHCA resuscitation have not been well studied.  In this podcast, we discuss a recent publication from Circulation that evaluated ventilation waveforms during OHCA resuscitation and the association of these metrics on patient outcomes.  Can we do better?]]></googleplay:description>
	<googleplay:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2024/04/ohca.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Steroids in Sepsis, ARDS, and CAP &#8211; A Focused Clinical Update</title>
	<link>https://ccpem.blog/podcast/steroids-in-sepsis-ards-and-cap-a-focused-clinical-update/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=steroids-in-sepsis-ards-and-cap-a-focused-clinical-update&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=steroids-in-sepsis-ards-and-cap-a-focused-clinical-update</link>
	<pubDate>Sun, 17 Mar 2024 01:02:41 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=2021</guid>
	<description><![CDATA[<p>Critically ill patients commonly develop a dysregulated inflammatory response. Corticosteroids are hypothesized to be beneficial due to their anti-inflammatory properties.&nbsp; In recent years, several studies have been published on the use of corticosteroids in select critical illnesses.&nbsp; In this podcast, we review a recently published clinical update on the use of corticosteroids in sepsis, ARDS, and community acquired pneumonia.</p>]]></description>
	<itunes:subtitle><![CDATA[Critically ill patients commonly develop a dysregulated inflammatory response. Corticosteroids are hypothesized to be beneficial due to their anti-inflammatory properties.&nbsp; In recent years, several studies have been published on the use of corticost]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Critically ill patients commonly develop a dysregulated inflammatory response. Corticosteroids are hypothesized to be beneficial due to their anti-inflammatory properties.&nbsp; In recent years, several studies have been published on the use of corticosteroids in select critical illnesses.&nbsp; In this podcast, we review a recently published clinical update on the use of corticosteroids in sepsis, ARDS, and community acquired pneumonia.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/2021/steroids-in-sepsis-ards-and-cap-a-focused-clinical-update.mp3" length="31771745" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Critically ill patients commonly develop a dysregulated inflammatory response. Corticosteroids are hypothesized to be beneficial due to their anti-inflammatory properties.&nbsp; In recent years, several studies have been published on the use of corticosteroids in select critical illnesses.&nbsp; In this podcast, we review a recently published clinical update on the use of corticosteroids in sepsis, ARDS, and community acquired pneumonia.]]></itunes:summary>
	<itunes:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2024/03/steroids.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i2.wp.com/ccpem.blog/wp-content/uploads/2024/03/steroids.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Steroids in Sepsis, ARDS, and CAP &#8211; A Focused Clinical Update</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:22:04</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Critically ill patients commonly develop a dysregulated inflammatory response. Corticosteroids are hypothesized to be beneficial due to their anti-inflammatory properties.&nbsp; In recent years, several studies have been published on the use of corticosteroids in select critical illnesses.&nbsp; In this podcast, we review a recently published clinical update on the use of corticosteroids in sepsis, ARDS, and community acquired pneumonia.]]></googleplay:description>
	<googleplay:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2024/03/steroids.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>A Year in Review &#8211; The 2023 Critical Care and Resuscitation Literature</title>
	<link>https://ccpem.blog/podcast/a-year-in-review-the-2023-critical-care-and-resuscitation-literature/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=a-year-in-review-the-2023-critical-care-and-resuscitation-literature&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=a-year-in-review-the-2023-critical-care-and-resuscitation-literature</link>
	<pubDate>Wed, 31 Jan 2024 01:37:18 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=2015</guid>
	<description><![CDATA[<p>In this podcast we review a few key articles from the 2023 critical care, emergency medicine, and resuscitation literature that pertain to our care of the critically ill ED patient.</p>]]></description>
	<itunes:subtitle><![CDATA[In this podcast we review a few key articles from the 2023 critical care, emergency medicine, and resuscitation literature that pertain to our care of the critically ill ED patient.]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>In this podcast we review a few key articles from the 2023 critical care, emergency medicine, and resuscitation literature that pertain to our care of the critically ill ED patient.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/2015/a-year-in-review-the-2023-critical-care-and-resuscitation-literature.mp3" length="57190472" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[In this podcast we review a few key articles from the 2023 critical care, emergency medicine, and resuscitation literature that pertain to our care of the critically ill ED patient.]]></itunes:summary>
	<itunes:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2024/01/ccpemreview2023.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i2.wp.com/ccpem.blog/wp-content/uploads/2024/01/ccpemreview2023.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>A Year in Review &#8211; The 2023 Critical Care and Resuscitation Literature</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:39:43</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[In this podcast we review a few key articles from the 2023 critical care, emergency medicine, and resuscitation literature that pertain to our care of the critically ill ED patient.]]></googleplay:description>
	<googleplay:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2024/01/ccpemreview2023.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Should We Intubate For GCS &#060; 8?</title>
	<link>https://ccpem.blog/podcast/should-we-intubate-for-gcs-8/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=should-we-intubate-for-gcs-8&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=should-we-intubate-for-gcs-8</link>
	<pubDate>Fri, 29 Dec 2023 17:05:25 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=2009</guid>
	<description><![CDATA[<p>Acute mental status changes after the ingestion of alcohol or other substances are a common presentation to the ED.  Those with severe obtundation may require intubation for airway protection while the substance metabolizes.  In fact, more than 20,000 patients are intubated each year in the United States for acute poisoning or intoxication.  Notwithstanding, intubation and mechanical ventilation are not benign procedures.  In this podcast we discuss the recently published NICO Trial, that evaluated a strategy of withholding intubation in patients with coma due to acute poisoning.</p>]]></description>
	<itunes:subtitle><![CDATA[Acute mental status changes after the ingestion of alcohol or other substances are a common presentation to the ED.  Those with severe obtundation may require intubation for airway protection while the substance metabolizes.  In fact, more than 20,000 pa]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Acute mental status changes after the ingestion of alcohol or other substances are a common presentation to the ED.  Those with severe obtundation may require intubation for airway protection while the substance metabolizes.  In fact, more than 20,000 patients are intubated each year in the United States for acute poisoning or intoxication.  Notwithstanding, intubation and mechanical ventilation are not benign procedures.  In this podcast we discuss the recently published NICO Trial, that evaluated a strategy of withholding intubation in patients with coma due to acute poisoning.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/2009/should-we-intubate-for-gcs-8.mp3" length="35872671" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Acute mental status changes after the ingestion of alcohol or other substances are a common presentation to the ED.  Those with severe obtundation may require intubation for airway protection while the substance metabolizes.  In fact, more than 20,000 patients are intubated each year in the United States for acute poisoning or intoxication.  Notwithstanding, intubation and mechanical ventilation are not benign procedures.  In this podcast we discuss the recently published NICO Trial, that evaluated a strategy of withholding intubation in patients with coma due to acute poisoning.]]></itunes:summary>
	<itunes:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2023/12/biggcs.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i1.wp.com/ccpem.blog/wp-content/uploads/2023/12/biggcs.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Should We Intubate For GCS &#060; 8?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:24:55</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Acute mental status changes after the ingestion of alcohol or other substances are a common presentation to the ED.  Those with severe obtundation may require intubation for airway protection while the substance metabolizes.  In fact, more than 20,000 patients are intubated each year in the United States for acute poisoning or intoxication.  Notwithstanding, intubation and mechanical ventilation are not benign procedures.  In this podcast we discuss the recently published NICO Trial, that evaluated a strategy of withholding intubation in patients with coma due to acute poisoning.]]></googleplay:description>
	<googleplay:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2023/12/biggcs.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Should We Be Placing REBOA?</title>
	<link>https://ccpem.blog/podcast/should-we-be-placing-reboa/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=should-we-be-placing-reboa&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=should-we-be-placing-reboa</link>
	<pubDate>Thu, 23 Nov 2023 12:48:46 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=2004</guid>
	<description><![CDATA[<p>REBOA is a relatively new and novel technique that in animal studies has demonstrated benefit in controlling hemorrhage.  However, the evidence for the efficacy of REBOA in humans remains scant.  In this podcast, we discuss the recently published UK-REBOA Trial, which randomized patients to receive REBOA with standard care compared to those randomized to standard care alone.  You may be surprised by these results!</p>]]></description>
	<itunes:subtitle><![CDATA[REBOA is a relatively new and novel technique that in animal studies has demonstrated benefit in controlling hemorrhage.  However, the evidence for the efficacy of REBOA in humans remains scant.  In this podcast, we discuss the recently published UK-REBO]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>REBOA is a relatively new and novel technique that in animal studies has demonstrated benefit in controlling hemorrhage.  However, the evidence for the efficacy of REBOA in humans remains scant.  In this podcast, we discuss the recently published UK-REBOA Trial, which randomized patients to receive REBOA with standard care compared to those randomized to standard care alone.  You may be surprised by these results!</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/2004/should-we-be-placing-reboa.mp3" length="35291117" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[REBOA is a relatively new and novel technique that in animal studies has demonstrated benefit in controlling hemorrhage.  However, the evidence for the efficacy of REBOA in humans remains scant.  In this podcast, we discuss the recently published UK-REBOA Trial, which randomized patients to receive REBOA with standard care compared to those randomized to standard care alone.  You may be surprised by these results!]]></itunes:summary>
	<itunes:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2023/11/reboa.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i0.wp.com/ccpem.blog/wp-content/uploads/2023/11/reboa.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Should We Be Placing REBOA?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:24:31</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[REBOA is a relatively new and novel technique that in animal studies has demonstrated benefit in controlling hemorrhage.  However, the evidence for the efficacy of REBOA in humans remains scant.  In this podcast, we discuss the recently published UK-REBOA Trial, which randomized patients to receive REBOA with standard care compared to those randomized to standard care alone.  You may be surprised by these results!]]></googleplay:description>
	<googleplay:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2023/11/reboa.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>SCCM Guidelines for RSI in the Critically Ill</title>
	<link>https://ccpem.blog/podcast/sccm-guidelines-for-rsi-in-the-critically-ill/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=sccm-guidelines-for-rsi-in-the-critically-ill&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=sccm-guidelines-for-rsi-in-the-critically-ill</link>
	<pubDate>Tue, 24 Oct 2023 02:29:18 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1998</guid>
	<description><![CDATA[<p>RSI is one of the most common procedures in critically ill patients.  Despite its frequency, there remains significant practice variation on numerous aspects of RSI in the critically ill.  In this podcast, we review pertinent recommendations from the recently published SCCM Guidelines on RSI in the critically ill patient.</p>]]></description>
	<itunes:subtitle><![CDATA[RSI is one of the most common procedures in critically ill patients.  Despite its frequency, there remains significant practice variation on numerous aspects of RSI in the critically ill.  In this podcast, we review pertinent recommendations from the rec]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>RSI is one of the most common procedures in critically ill patients.  Despite its frequency, there remains significant practice variation on numerous aspects of RSI in the critically ill.  In this podcast, we review pertinent recommendations from the recently published SCCM Guidelines on RSI in the critically ill patient.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1998/sccm-guidelines-for-rsi-in-the-critically-ill.mp3" length="47766671" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[RSI is one of the most common procedures in critically ill patients.  Despite its frequency, there remains significant practice variation on numerous aspects of RSI in the critically ill.  In this podcast, we review pertinent recommendations from the recently published SCCM Guidelines on RSI in the critically ill patient.]]></itunes:summary>
	<itunes:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2023/10/RSI.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i1.wp.com/ccpem.blog/wp-content/uploads/2023/10/RSI.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>SCCM Guidelines for RSI in the Critically Ill</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:33:10</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[RSI is one of the most common procedures in critically ill patients.  Despite its frequency, there remains significant practice variation on numerous aspects of RSI in the critically ill.  In this podcast, we review pertinent recommendations from the recently published SCCM Guidelines on RSI in the critically ill patient.]]></googleplay:description>
	<googleplay:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2023/10/RSI.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Post-Arrest Care Updates &#8211; Are Mild Hypercapnia and a Pan-CT Protocol Useful?</title>
	<link>https://ccpem.blog/podcast/post-arrest-care-updates-are-mild-hypercapnia-and-a-pan-ct-protocol-useful/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=post-arrest-care-updates-are-mild-hypercapnia-and-a-pan-ct-protocol-useful&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=post-arrest-care-updates-are-mild-hypercapnia-and-a-pan-ct-protocol-useful</link>
	<pubDate>Fri, 08 Sep 2023 16:01:53 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1992</guid>
	<description><![CDATA[<p>Care of the patient with ROSC following OHCA can be complex and typically includes a protocolized approach to optimizing oxygenation, ventilation, hemodynamics, early cardiac catheterization for patients with STEMI, seizure detection, and possibly TTM.&nbsp; In this podcast, we review two recent articles that focused on the use of mild hypercapnia compared with normocapnia in post arrest patients and the use of a pan-CT protocol to detect critical time sensitive conditions and complications.</p>]]></description>
	<itunes:subtitle><![CDATA[Care of the patient with ROSC following OHCA can be complex and typically includes a protocolized approach to optimizing oxygenation, ventilation, hemodynamics, early cardiac catheterization for patients with STEMI, seizure detection, and possibly TTM.&n]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Care of the patient with ROSC following OHCA can be complex and typically includes a protocolized approach to optimizing oxygenation, ventilation, hemodynamics, early cardiac catheterization for patients with STEMI, seizure detection, and possibly TTM.&nbsp; In this podcast, we review two recent articles that focused on the use of mild hypercapnia compared with normocapnia in post arrest patients and the use of a pan-CT protocol to detect critical time sensitive conditions and complications.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1992/post-arrest-care-updates-are-mild-hypercapnia-and-a-pan-ct-protocol-useful.mp3" length="49679101" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Care of the patient with ROSC following OHCA can be complex and typically includes a protocolized approach to optimizing oxygenation, ventilation, hemodynamics, early cardiac catheterization for patients with STEMI, seizure detection, and possibly TTM.&nbsp; In this podcast, we review two recent articles that focused on the use of mild hypercapnia compared with normocapnia in post arrest patients and the use of a pan-CT protocol to detect critical time sensitive conditions and complications.]]></itunes:summary>
	<itunes:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2023/09/pacu.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i2.wp.com/ccpem.blog/wp-content/uploads/2023/09/pacu.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Post-Arrest Care Updates &#8211; Are Mild Hypercapnia and a Pan-CT Protocol Useful?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:34:29</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Care of the patient with ROSC following OHCA can be complex and typically includes a protocolized approach to optimizing oxygenation, ventilation, hemodynamics, early cardiac catheterization for patients with STEMI, seizure detection, and possibly TTM.&nbsp; In this podcast, we review two recent articles that focused on the use of mild hypercapnia compared with normocapnia in post arrest patients and the use of a pan-CT protocol to detect critical time sensitive conditions and complications.]]></googleplay:description>
	<googleplay:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2023/09/pacu.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Should We Transfuse Platelets Prior to CVC Placement?</title>
	<link>https://ccpem.blog/podcast/should-we-transfuse-platelets-prior-to-cvc-placement/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=should-we-transfuse-platelets-prior-to-cvc-placement&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=should-we-transfuse-platelets-prior-to-cvc-placement</link>
	<pubDate>Fri, 28 Jul 2023 14:37:02 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1985</guid>
	<description><![CDATA[<p>Central venous catheter (CVC) placement is common in critically ill patients for a variety of indications.  Thrombocytopenia is also quite common in critically ill patients.  Unfortunately, literature and guideline recommendations vary on the threshold for prophylactic platelet transfusion in patients undergoing a procedure.  In this podcast we discuss a recent trial that evaluated prophylactic platelet transfusion in patients with severe thrombocytopenia undergoing CVC placement.</p>]]></description>
	<itunes:subtitle><![CDATA[Central venous catheter (CVC) placement is common in critically ill patients for a variety of indications.  Thrombocytopenia is also quite common in critically ill patients.  Unfortunately, literature and guideline recommendations vary on the threshold f]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Central venous catheter (CVC) placement is common in critically ill patients for a variety of indications.  Thrombocytopenia is also quite common in critically ill patients.  Unfortunately, literature and guideline recommendations vary on the threshold for prophylactic platelet transfusion in patients undergoing a procedure.  In this podcast we discuss a recent trial that evaluated prophylactic platelet transfusion in patients with severe thrombocytopenia undergoing CVC placement.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1985/should-we-transfuse-platelets-prior-to-cvc-placement.mp3" length="37854587" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Central venous catheter (CVC) placement is common in critically ill patients for a variety of indications.  Thrombocytopenia is also quite common in critically ill patients.  Unfortunately, literature and guideline recommendations vary on the threshold for prophylactic platelet transfusion in patients undergoing a procedure.  In this podcast we discuss a recent trial that evaluated prophylactic platelet transfusion in patients with severe thrombocytopenia undergoing CVC placement.]]></itunes:summary>
	<itunes:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2023/07/platelets.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i1.wp.com/ccpem.blog/wp-content/uploads/2023/07/platelets.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Should We Transfuse Platelets Prior to CVC Placement?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:26:16</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Central venous catheter (CVC) placement is common in critically ill patients for a variety of indications.  Thrombocytopenia is also quite common in critically ill patients.  Unfortunately, literature and guideline recommendations vary on the threshold for prophylactic platelet transfusion in patients undergoing a procedure.  In this podcast we discuss a recent trial that evaluated prophylactic platelet transfusion in patients with severe thrombocytopenia undergoing CVC placement.]]></googleplay:description>
	<googleplay:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2023/07/platelets.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>VL versus DL&#8230;And The Winner Is?</title>
	<link>https://ccpem.blog/podcast/vl-versus-dl-and-the-winner-is/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=vl-versus-dl-and-the-winner-is&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=vl-versus-dl-and-the-winner-is</link>
	<pubDate>Fri, 07 Jul 2023 01:06:10 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">http://ccpem.blog/?post_type=podcast&#038;p=1981</guid>
	<description><![CDATA[<p>Over 1 million critically ill patients undergo intubation each year in the United States.&nbsp; Though direct laryngoscopy remains the most common technique worldwide for intubation, the use of video laryngoscopy has significantly&nbsp;increased.&nbsp; Studies evaluating video to direct laryngoscopy have thus far produced mixed results.&nbsp; In this podcast, we review the latest randomized trial, the DEVICE Trial, that assessed video with direct laryngoscopy.&nbsp; Which device won?</p>]]></description>
	<itunes:subtitle><![CDATA[Over 1 million critically ill patients undergo intubation each year in the United States.&nbsp; Though direct laryngoscopy remains the most common technique worldwide for intubation, the use of video laryngoscopy has significantly&nbsp;increased.&nbsp; S]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Over 1 million critically ill patients undergo intubation each year in the United States.&nbsp; Though direct laryngoscopy remains the most common technique worldwide for intubation, the use of video laryngoscopy has significantly&nbsp;increased.&nbsp; Studies evaluating video to direct laryngoscopy have thus far produced mixed results.&nbsp; In this podcast, we review the latest randomized trial, the DEVICE Trial, that assessed video with direct laryngoscopy.&nbsp; Which device won?</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1981/vl-versus-dl-and-the-winner-is.mp3" length="41676943" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Over 1 million critically ill patients undergo intubation each year in the United States.&nbsp; Though direct laryngoscopy remains the most common technique worldwide for intubation, the use of video laryngoscopy has significantly&nbsp;increased.&nbsp; Studies evaluating video to direct laryngoscopy have thus far produced mixed results.&nbsp; In this podcast, we review the latest randomized trial, the DEVICE Trial, that assessed video with direct laryngoscopy.&nbsp; Which device won?]]></itunes:summary>
	<itunes:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2023/07/vlvsdl.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i0.wp.com/ccpem.blog/wp-content/uploads/2023/07/vlvsdl.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>VL versus DL&#8230;And The Winner Is?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:28:56</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Over 1 million critically ill patients undergo intubation each year in the United States.&nbsp; Though direct laryngoscopy remains the most common technique worldwide for intubation, the use of video laryngoscopy has significantly&nbsp;increased.&nbsp; Studies evaluating video to direct laryngoscopy have thus far produced mixed results.&nbsp; In this podcast, we review the latest randomized trial, the DEVICE Trial, that assessed video with direct laryngoscopy.&nbsp; Which device won?]]></googleplay:description>
	<googleplay:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2023/07/vlvsdl.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Do Etomidate and Propofol Increase Mortality in the Critically Ill?</title>
	<link>https://ccpem.blog/podcast/do-etomidate-and-propofol-increase-mortality-in-the-critically-ill/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=do-etomidate-and-propofol-increase-mortality-in-the-critically-ill&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=do-etomidate-and-propofol-increase-mortality-in-the-critically-ill</link>
	<pubDate>Thu, 15 Jun 2023 01:19:20 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1973</guid>
	<description><![CDATA[<p>Both etomidate and propofol are commonly used sedative agents in critically ill patients.  Recent literature has suggested that these agents may result in increased harm and mortality.  In this podcast, we discuss the most recent two systematic reviews and meta-analyses that evaluated etomidate and propofol in critically ill patients.  Do we need to change our practice?</p>]]></description>
	<itunes:subtitle><![CDATA[Both etomidate and propofol are commonly used sedative agents in critically ill patients.  Recent literature has suggested that these agents may result in increased harm and mortality.  In this podcast, we discuss the most recent two systematic reviews a]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Both etomidate and propofol are commonly used sedative agents in critically ill patients.  Recent literature has suggested that these agents may result in increased harm and mortality.  In this podcast, we discuss the most recent two systematic reviews and meta-analyses that evaluated etomidate and propofol in critically ill patients.  Do we need to change our practice?</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1973/do-etomidate-and-propofol-increase-mortality-in-the-critically-ill.mp3" length="43729705" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Both etomidate and propofol are commonly used sedative agents in critically ill patients.  Recent literature has suggested that these agents may result in increased harm and mortality.  In this podcast, we discuss the most recent two systematic reviews and meta-analyses that evaluated etomidate and propofol in critically ill patients.  Do we need to change our practice?]]></itunes:summary>
	<itunes:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2023/06/propofol.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i2.wp.com/ccpem.blog/wp-content/uploads/2023/06/propofol.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Do Etomidate and Propofol Increase Mortality in the Critically Ill?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:30:21</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Both etomidate and propofol are commonly used sedative agents in critically ill patients.  Recent literature has suggested that these agents may result in increased harm and mortality.  In this podcast, we discuss the most recent two systematic reviews and meta-analyses that evaluated etomidate and propofol in critically ill patients.  Do we need to change our practice?]]></googleplay:description>
	<googleplay:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2023/06/propofol.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Should We Add Fludrocortisone to Hydrocortisone for Septic Shock?</title>
	<link>https://ccpem.blog/podcast/should-we-add-fludrocortisone-to-hydrocortisone-for-septic-shock/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=should-we-add-fludrocortisone-to-hydrocortisone-for-septic-shock&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=should-we-add-fludrocortisone-to-hydrocortisone-for-septic-shock</link>
	<pubDate>Fri, 28 Apr 2023 16:26:20 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1957</guid>
	<description><![CDATA[<p><strong>The use of steroids in patients with sepsis and septic shock has been controversial for decades. At present, the Surviving Sepsis Campaign recommends the administration of corticosteroids to patients with persistent shock despite fluid and vasopressor administration. In recent years, several trials have evaluated the addition of fludrocortisone, a potent mineralocorticoid, to hydrocortisone in septic shock. In this podcast, we review the latest study that evaluated the combination of hydrocortisone and fludrocortisone in patients with septic shock.Â  Should we administer this medication with hydrocortisone for our patients with septic shock?</strong></p>]]></description>
	<itunes:subtitle><![CDATA[The use of steroids in patients with sepsis and septic shock has been controversial for decades. At present, the Surviving Sepsis Campaign recommends the administration of corticosteroids to patients with persistent shock despite fluid and vasopressor ad]]></itunes:subtitle>
	<content:encoded><![CDATA[<p><strong>The use of steroids in patients with sepsis and septic shock has been controversial for decades. At present, the Surviving Sepsis Campaign recommends the administration of corticosteroids to patients with persistent shock despite fluid and vasopressor administration. In recent years, several trials have evaluated the addition of fludrocortisone, a potent mineralocorticoid, to hydrocortisone in septic shock. In this podcast, we review the latest study that evaluated the combination of hydrocortisone and fludrocortisone in patients with septic shock.Â  Should we administer this medication with hydrocortisone for our patients with septic shock?</strong></p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1957/should-we-add-fludrocortisone-to-hydrocortisone-for-septic-shock.mp3" length="39398929" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[The use of steroids in patients with sepsis and septic shock has been controversial for decades. At present, the Surviving Sepsis Campaign recommends the administration of corticosteroids to patients with persistent shock despite fluid and vasopressor administration. In recent years, several trials have evaluated the addition of fludrocortisone, a potent mineralocorticoid, to hydrocortisone in septic shock. In this podcast, we review the latest study that evaluated the combination of hydrocortisone and fludrocortisone in patients with septic shock.Â  Should we administer this medication with hydrocortisone for our patients with septic shock?]]></itunes:summary>
	<itunes:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2023/04/sscsepsis.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i0.wp.com/ccpem.blog/wp-content/uploads/2023/04/sscsepsis.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Should We Add Fludrocortisone to Hydrocortisone for Septic Shock?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:27:21</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[The use of steroids in patients with sepsis and septic shock has been controversial for decades. At present, the Surviving Sepsis Campaign recommends the administration of corticosteroids to patients with persistent shock despite fluid and vasopressor administration. In recent years, several trials have evaluated the addition of fludrocortisone, a potent mineralocorticoid, to hydrocortisone in septic shock. In this podcast, we review the latest study that evaluated the combination of hydrocortisone and fludrocortisone in patients with septic shock.Â  Should we administer this medication with hydrocortisone for our patients with septic shock?]]></googleplay:description>
	<googleplay:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2023/04/sscsepsis.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Should We Administer Steroids in Severe CAP?</title>
	<link>https://ccpem.blog/podcast/should-we-administer-steroids-in-severe-cap/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=should-we-administer-steroids-in-severe-cap&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=should-we-administer-steroids-in-severe-cap</link>
	<pubDate>Thu, 13 Apr 2023 00:49:17 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1952</guid>
	<description><![CDATA[<p>In recent years,Â  numerous trials have investigated the administration of corticosteroids in patients with pneumonia and have produced mixed results.Â  In this podcast, we discuss the latest randomized trial, the CAPE COD trial, that evaluated whether the administration of hydrocortisone to ICU patients with severe CAP reduced mortality.Â  Is this a therapy we should look to administer in the ED based on the results of this trial?Â  Take a listen and find out...</p>]]></description>
	<itunes:subtitle><![CDATA[In recent years,Â  numerous trials have investigated the administration of corticosteroids in patients with pneumonia and have produced mixed results.Â  In this podcast, we discuss the latest randomized trial, the CAPE COD trial, that evaluated whether t]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>In recent years,Â  numerous trials have investigated the administration of corticosteroids in patients with pneumonia and have produced mixed results.Â  In this podcast, we discuss the latest randomized trial, the CAPE COD trial, that evaluated whether the administration of hydrocortisone to ICU patients with severe CAP reduced mortality.Â  Is this a therapy we should look to administer in the ED based on the results of this trial?Â  Take a listen and find out...</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1952/should-we-administer-steroids-in-severe-cap.mp3" length="41743338" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[In recent years,Â  numerous trials have investigated the administration of corticosteroids in patients with pneumonia and have produced mixed results.Â  In this podcast, we discuss the latest randomized trial, the CAPE COD trial, that evaluated whether the administration of hydrocortisone to ICU patients with severe CAP reduced mortality.Â  Is this a therapy we should look to administer in the ED based on the results of this trial?Â  Take a listen and find out...]]></itunes:summary>
	<itunes:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2023/04/capsteroids.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i2.wp.com/ccpem.blog/wp-content/uploads/2023/04/capsteroids.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Should We Administer Steroids in Severe CAP?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:28:58</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[In recent years,Â  numerous trials have investigated the administration of corticosteroids in patients with pneumonia and have produced mixed results.Â  In this podcast, we discuss the latest randomized trial, the CAPE COD trial, that evaluated whether the administration of hydrocortisone to ICU patients with severe CAP reduced mortality.Â  Is this a therapy we should look to administer in the ED based on the results of this trial?Â  Take a listen and find out...]]></googleplay:description>
	<googleplay:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2023/04/capsteroids.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>ECPR for OHCA? &#8211; The INCEPTION Trial</title>
	<link>https://ccpem.blog/podcast/ecpr-for-ohca-the-inception-trial/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=ecpr-for-ohca-the-inception-trial&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=ecpr-for-ohca-the-inception-trial</link>
	<pubDate>Mon, 27 Feb 2023 23:07:58 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1945</guid>
	<description><![CDATA[<p>In recent years, several single center trials have demonstrated positive outcomes in patients with OHCA randomized to receive ECPR compared with patients who received standard resuscitation.Â Â Not surprisingly, these single center studies have limitations that impact the generalizability of these results.Â Â In the current podcast, we discuss the recently published INCEPTION Trial, which is a multicenter, randomized trial that compared the effect of extracorporeal CPR with conventional CPR in patients with refractory OHCA due to a ventricular arrhythmia.</p>]]></description>
	<itunes:subtitle><![CDATA[In recent years, several single center trials have demonstrated positive outcomes in patients with OHCA randomized to receive ECPR compared with patients who received standard resuscitation.Â Â Not surprisingly, these single center studies have limitatio]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>In recent years, several single center trials have demonstrated positive outcomes in patients with OHCA randomized to receive ECPR compared with patients who received standard resuscitation.Â Â Not surprisingly, these single center studies have limitations that impact the generalizability of these results.Â Â In the current podcast, we discuss the recently published INCEPTION Trial, which is a multicenter, randomized trial that compared the effect of extracorporeal CPR with conventional CPR in patients with refractory OHCA due to a ventricular arrhythmia.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1945/ecpr-for-ohca-the-inception-trial.mp3" length="40212103" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[In recent years, several single center trials have demonstrated positive outcomes in patients with OHCA randomized to receive ECPR compared with patients who received standard resuscitation.Â Â Not surprisingly, these single center studies have limitations that impact the generalizability of these results.Â Â In the current podcast, we discuss the recently published INCEPTION Trial, which is a multicenter, randomized trial that compared the effect of extracorporeal CPR with conventional CPR in patients with refractory OHCA due to a ventricular arrhythmia.]]></itunes:summary>
	<itunes:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2023/02/inceptiontrial.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i1.wp.com/ccpem.blog/wp-content/uploads/2023/02/inceptiontrial.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>ECPR for OHCA? &#8211; The INCEPTION Trial</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:27:55</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[In recent years, several single center trials have demonstrated positive outcomes in patients with OHCA randomized to receive ECPR compared with patients who received standard resuscitation.Â Â Not surprisingly, these single center studies have limitations that impact the generalizability of these results.Â Â In the current podcast, we discuss the recently published INCEPTION Trial, which is a multicenter, randomized trial that compared the effect of extracorporeal CPR with conventional CPR in patients with refractory OHCA due to a ventricular arrhythmia.]]></googleplay:description>
	<googleplay:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2023/02/inceptiontrial.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Should We Use a Liberal or Restrictive Fluid Strategy in Sepsis &#8211; The CLOVERS Trial</title>
	<link>https://ccpem.blog/podcast/should-we-use-a-liberal-or-restrictive-fluid-strategy-in-sepsis-the-clovers-trial/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=should-we-use-a-liberal-or-restrictive-fluid-strategy-in-sepsis-the-clovers-trial&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=should-we-use-a-liberal-or-restrictive-fluid-strategy-in-sepsis-the-clovers-trial</link>
	<pubDate>Tue, 07 Feb 2023 15:32:28 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1940</guid>
	<description><![CDATA[<p>Intravenous fluid (IVF) administration is a central tenet to the resuscitation of patients with sepsis and sepsis-induced hypotension.&nbsp; At present, the administration of large volumes of IVF is common, though based on low quality of evidence.&nbsp; In this podcast, we review and interpret the recently published CLOVERS Trial, which compared the use of a liberal fluid strategy with a restrictive fluid strategy in patients with sepsis-induced hypotension.</p>]]></description>
	<itunes:subtitle><![CDATA[Intravenous fluid (IVF) administration is a central tenet to the resuscitation of patients with sepsis and sepsis-induced hypotension.&nbsp; At present, the administration of large volumes of IVF is common, though based on low quality of evidence.&nbsp; ]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Intravenous fluid (IVF) administration is a central tenet to the resuscitation of patients with sepsis and sepsis-induced hypotension.&nbsp; At present, the administration of large volumes of IVF is common, though based on low quality of evidence.&nbsp; In this podcast, we review and interpret the recently published CLOVERS Trial, which compared the use of a liberal fluid strategy with a restrictive fluid strategy in patients with sepsis-induced hypotension.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1940/should-we-use-a-liberal-or-restrictive-fluid-strategy-in-sepsis-the-clovers-trial.mp3" length="36608847" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Intravenous fluid (IVF) administration is a central tenet to the resuscitation of patients with sepsis and sepsis-induced hypotension.&nbsp; At present, the administration of large volumes of IVF is common, though based on low quality of evidence.&nbsp; In this podcast, we review and interpret the recently published CLOVERS Trial, which compared the use of a liberal fluid strategy with a restrictive fluid strategy in patients with sepsis-induced hypotension.]]></itunes:summary>
	<itunes:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2023/02/clovers.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i1.wp.com/ccpem.blog/wp-content/uploads/2023/02/clovers.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Should We Use a Liberal or Restrictive Fluid Strategy in Sepsis &#8211; The CLOVERS Trial</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:25:24</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Intravenous fluid (IVF) administration is a central tenet to the resuscitation of patients with sepsis and sepsis-induced hypotension.&nbsp; At present, the administration of large volumes of IVF is common, though based on low quality of evidence.&nbsp; In this podcast, we review and interpret the recently published CLOVERS Trial, which compared the use of a liberal fluid strategy with a restrictive fluid strategy in patients with sepsis-induced hypotension.]]></googleplay:description>
	<googleplay:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2023/02/clovers.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Top Critical Care Articles of 2022</title>
	<link>https://ccpem.blog/podcast/top-critical-care-articles-of-2022/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=top-critical-care-articles-of-2022&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=top-critical-care-articles-of-2022</link>
	<pubDate>Mon, 23 Jan 2023 05:05:44 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1935</guid>
	<description><![CDATA[<p>Given the increase in critically ill patients who present to the ED in need of resuscitation, along with the increase in those who board in the ED awaiting an ICU bed, it is imperative that the emergency physician be knowledgeable about recent literature in resuscitation and critical care medicine. In this podcast, we discuss important articles published in 2022 that pertain to care of critically ill ED patients.</p>]]></description>
	<itunes:subtitle><![CDATA[Given the increase in critically ill patients who present to the ED in need of resuscitation, along with the increase in those who board in the ED awaiting an ICU bed, it is imperative that the emergency physician be knowledgeable about recent literature]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Given the increase in critically ill patients who present to the ED in need of resuscitation, along with the increase in those who board in the ED awaiting an ICU bed, it is imperative that the emergency physician be knowledgeable about recent literature in resuscitation and critical care medicine. In this podcast, we discuss important articles published in 2022 that pertain to care of critically ill ED patients.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1935/top-critical-care-articles-of-2022.mp3" length="65427383" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Given the increase in critically ill patients who present to the ED in need of resuscitation, along with the increase in those who board in the ED awaiting an ICU bed, it is imperative that the emergency physician be knowledgeable about recent literature in resuscitation and critical care medicine. In this podcast, we discuss important articles published in 2022 that pertain to care of critically ill ED patients.]]></itunes:summary>
	<itunes:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2023/01/toparticles2022.png?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i2.wp.com/ccpem.blog/wp-content/uploads/2023/01/toparticles2022.png?fit=1000%2C300&#038;ssl=1</url>
		<title>Top Critical Care Articles of 2022</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:45:25</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Given the increase in critically ill patients who present to the ED in need of resuscitation, along with the increase in those who board in the ED awaiting an ICU bed, it is imperative that the emergency physician be knowledgeable about recent literature in resuscitation and critical care medicine. In this podcast, we discuss important articles published in 2022 that pertain to care of critically ill ED patients.]]></googleplay:description>
	<googleplay:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2023/01/toparticles2022.png?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Double Sequential External Defibrillation for Refractory Ventricular Fibrillation</title>
	<link>https://ccpem.blog/podcast/double-sequential-external-defibrillation-for-refractory-ventricular-fibrillation/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=double-sequential-external-defibrillation-for-refractory-ventricular-fibrillation&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=double-sequential-external-defibrillation-for-refractory-ventricular-fibrillation</link>
	<pubDate>Mon, 12 Dec 2022 14:35:36 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1929</guid>
	<description><![CDATA[<p>More than 350,000 cardiac arrests occur each year in North America.Â  Approximately 100,000 of these arrests are due to shockable rhythms.Â  Unfortunately, many patients have refractory ventricular fibrillation and do not respond to many attempts at standard defibrillation.Â  In this podcast, we discuss a recent study that evaluated double sequential external defibrillation and vector-change defibrillation compared to standard defibrillation in patients with refractory ventricular fibrillation in OHCA.</p>]]></description>
	<itunes:subtitle><![CDATA[More than 350,000 cardiac arrests occur each year in North America.Â  Approximately 100,000 of these arrests are due to shockable rhythms.Â  Unfortunately, many patients have refractory ventricular fibrillation and do not respond to many attempts at stan]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>More than 350,000 cardiac arrests occur each year in North America.Â  Approximately 100,000 of these arrests are due to shockable rhythms.Â  Unfortunately, many patients have refractory ventricular fibrillation and do not respond to many attempts at standard defibrillation.Â  In this podcast, we discuss a recent study that evaluated double sequential external defibrillation and vector-change defibrillation compared to standard defibrillation in patients with refractory ventricular fibrillation in OHCA.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1929/double-sequential-external-defibrillation-for-refractory-ventricular-fibrillation.mp3" length="35368115" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[More than 350,000 cardiac arrests occur each year in North America.Â  Approximately 100,000 of these arrests are due to shockable rhythms.Â  Unfortunately, many patients have refractory ventricular fibrillation and do not respond to many attempts at standard defibrillation.Â  In this podcast, we discuss a recent study that evaluated double sequential external defibrillation and vector-change defibrillation compared to standard defibrillation in patients with refractory ventricular fibrillation in OHCA.]]></itunes:summary>
	<itunes:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2022/12/doubledefib.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i1.wp.com/ccpem.blog/wp-content/uploads/2022/12/doubledefib.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Double Sequential External Defibrillation for Refractory Ventricular Fibrillation</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:24:33</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[More than 350,000 cardiac arrests occur each year in North America.Â  Approximately 100,000 of these arrests are due to shockable rhythms.Â  Unfortunately, many patients have refractory ventricular fibrillation and do not respond to many attempts at standard defibrillation.Â  In this podcast, we discuss a recent study that evaluated double sequential external defibrillation and vector-change defibrillation compared to standard defibrillation in patients with refractory ventricular fibrillation in OHCA.]]></googleplay:description>
	<googleplay:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2022/12/doubledefib.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>What is the Optimal SpO2 Target in Vented Patients?</title>
	<link>https://ccpem.blog/podcast/what-is-the-optimal-spo2-target-in-vented-patients/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=what-is-the-optimal-spo2-target-in-vented-patients&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=what-is-the-optimal-spo2-target-in-vented-patients</link>
	<pubDate>Wed, 09 Nov 2022 15:45:29 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1924</guid>
	<description><![CDATA[<p>Approximately 3 million critically ill patients are intubated and initiated on mechanical ventilation each year in the United States. A critical component of mechanical ventilation is the adjustment of FiO2 to maintain adequate arterial oxygen saturation.Â Â However, the optimal oxygenation target in critically ill adult patients receiving mechanical ventilation remains uncertain. In this podcast we discuss a recently published study, the PILOT Trial, that evaluated low, intermediate, and high oxygenation targets in critically ill patients.</p>]]></description>
	<itunes:subtitle><![CDATA[Approximately 3 million critically ill patients are intubated and initiated on mechanical ventilation each year in the United States. A critical component of mechanical ventilation is the adjustment of FiO2 to maintain adequate arterial oxygen saturation]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Approximately 3 million critically ill patients are intubated and initiated on mechanical ventilation each year in the United States. A critical component of mechanical ventilation is the adjustment of FiO2 to maintain adequate arterial oxygen saturation.Â Â However, the optimal oxygenation target in critically ill adult patients receiving mechanical ventilation remains uncertain. In this podcast we discuss a recently published study, the PILOT Trial, that evaluated low, intermediate, and high oxygenation targets in critically ill patients.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1924/what-is-the-optimal-spo2-target-in-vented-patients.mp3" length="36320261" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Approximately 3 million critically ill patients are intubated and initiated on mechanical ventilation each year in the United States. A critical component of mechanical ventilation is the adjustment of FiO2 to maintain adequate arterial oxygen saturation.Â Â However, the optimal oxygenation target in critically ill adult patients receiving mechanical ventilation remains uncertain. In this podcast we discuss a recently published study, the PILOT Trial, that evaluated low, intermediate, and high oxygenation targets in critically ill patients.]]></itunes:summary>
	<itunes:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2022/11/spo2.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i2.wp.com/ccpem.blog/wp-content/uploads/2022/11/spo2.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>What is the Optimal SpO2 Target in Vented Patients?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:25:12</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Approximately 3 million critically ill patients are intubated and initiated on mechanical ventilation each year in the United States. A critical component of mechanical ventilation is the adjustment of FiO2 to maintain adequate arterial oxygen saturation.Â Â However, the optimal oxygenation target in critically ill adult patients receiving mechanical ventilation remains uncertain. In this podcast we discuss a recently published study, the PILOT Trial, that evaluated low, intermediate, and high oxygenation targets in critically ill patients.]]></googleplay:description>
	<googleplay:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2022/11/spo2.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Does the Timing of Source Control in Sepsis Make a Difference?</title>
	<link>https://ccpem.blog/podcast/does-the-timing-of-source-control-in-sepsis-make-a-difference/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=does-the-timing-of-source-control-in-sepsis-make-a-difference&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=does-the-timing-of-source-control-in-sepsis-make-a-difference</link>
	<pubDate>Thu, 20 Oct 2022 02:59:08 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1919</guid>
	<description><![CDATA[<p>The emergency department resuscitation of patients with sepsis focuses on early recognition, timely administration of appropriate antibiotics, appropriate fluid resuscitation, early vasopressor initiation for patients with sepsis-induced hypoperfusion, and hemodynamic monitoring.&nbsp;&nbsp;Source control is also an important component in the resuscitation of patients with sepsis.&nbsp;&nbsp;Though current guidelines identify source control as a "best practice" the optimal timing of source control remains uncertain.&nbsp;&nbsp;In this podcast, we discuss a recent study that evaluated the timing of source control with mortality in patients with community-acquired sepsis.</p>]]></description>
	<itunes:subtitle><![CDATA[The emergency department resuscitation of patients with sepsis focuses on early recognition, timely administration of appropriate antibiotics, appropriate fluid resuscitation, early vasopressor initiation for patients with sepsis-induced hypoperfusion, a]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>The emergency department resuscitation of patients with sepsis focuses on early recognition, timely administration of appropriate antibiotics, appropriate fluid resuscitation, early vasopressor initiation for patients with sepsis-induced hypoperfusion, and hemodynamic monitoring.&nbsp;&nbsp;Source control is also an important component in the resuscitation of patients with sepsis.&nbsp;&nbsp;Though current guidelines identify source control as a "best practice" the optimal timing of source control remains uncertain.&nbsp;&nbsp;In this podcast, we discuss a recent study that evaluated the timing of source control with mortality in patients with community-acquired sepsis.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1919/does-the-timing-of-source-control-in-sepsis-make-a-difference.mp3" length="26708657" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[The emergency department resuscitation of patients with sepsis focuses on early recognition, timely administration of appropriate antibiotics, appropriate fluid resuscitation, early vasopressor initiation for patients with sepsis-induced hypoperfusion, and hemodynamic monitoring.&nbsp;&nbsp;Source control is also an important component in the resuscitation of patients with sepsis.&nbsp;&nbsp;Though current guidelines identify source control as a "best practice" the optimal timing of source control remains uncertain.&nbsp;&nbsp;In this podcast, we discuss a recent study that evaluated the timing of source control with mortality in patients with community-acquired sepsis.]]></itunes:summary>
	<itunes:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2022/10/sepsis.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i2.wp.com/ccpem.blog/wp-content/uploads/2022/10/sepsis.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Does the Timing of Source Control in Sepsis Make a Difference?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:18:32</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[The emergency department resuscitation of patients with sepsis focuses on early recognition, timely administration of appropriate antibiotics, appropriate fluid resuscitation, early vasopressor initiation for patients with sepsis-induced hypoperfusion, and hemodynamic monitoring.&nbsp;&nbsp;Source control is also an important component in the resuscitation of patients with sepsis.&nbsp;&nbsp;Though current guidelines identify source control as a "best practice" the optimal timing of source control remains uncertain.&nbsp;&nbsp;In this podcast, we discuss a recent study that evaluated the timing of source control with mortality in patients with community-acquired sepsis.]]></googleplay:description>
	<googleplay:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2022/10/sepsis.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Does a Restrictive Oxygenation Target Make a Difference in the Post-Arrest Patient?</title>
	<link>https://ccpem.blog/podcast/does-a-restrictive-oxygenation-target-make-a-difference-in-the-post-arrest-patient/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=does-a-restrictive-oxygenation-target-make-a-difference-in-the-post-arrest-patient&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=does-a-restrictive-oxygenation-target-make-a-difference-in-the-post-arrest-patient</link>
	<pubDate>Mon, 03 Oct 2022 13:37:01 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1914</guid>
	<description><![CDATA[<p>The care of patients with return of spontaneous circulation following cardiac arrest centers on optimizing oxygenation and ventilation, optimizing hemodynamics, identifying patients that require immediate coronary angiography, detecting seizures, and targeted temperature management.Â Â In recent years, numerous articles have evaluated various components of this post-arrest bundle of care.Â Â In the current podcast, we discuss Part II of the BOX Trial that evaluated a restrictive versus liberal oxygenation target in the post-arrest patient.</p>]]></description>
	<itunes:subtitle><![CDATA[The care of patients with return of spontaneous circulation following cardiac arrest centers on optimizing oxygenation and ventilation, optimizing hemodynamics, identifying patients that require immediate coronary angiography, detecting seizures, and tar]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>The care of patients with return of spontaneous circulation following cardiac arrest centers on optimizing oxygenation and ventilation, optimizing hemodynamics, identifying patients that require immediate coronary angiography, detecting seizures, and targeted temperature management.Â Â In recent years, numerous articles have evaluated various components of this post-arrest bundle of care.Â Â In the current podcast, we discuss Part II of the BOX Trial that evaluated a restrictive versus liberal oxygenation target in the post-arrest patient.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1914/does-a-restrictive-oxygenation-target-make-a-difference-in-the-post-arrest-patient.mp3" length="36521437" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[The care of patients with return of spontaneous circulation following cardiac arrest centers on optimizing oxygenation and ventilation, optimizing hemodynamics, identifying patients that require immediate coronary angiography, detecting seizures, and targeted temperature management.Â Â In recent years, numerous articles have evaluated various components of this post-arrest bundle of care.Â Â In the current podcast, we discuss Part II of the BOX Trial that evaluated a restrictive versus liberal oxygenation target in the post-arrest patient.]]></itunes:summary>
	<itunes:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2022/10/boxtrial.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i1.wp.com/ccpem.blog/wp-content/uploads/2022/10/boxtrial.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Does a Restrictive Oxygenation Target Make a Difference in the Post-Arrest Patient?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:25:21</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[The care of patients with return of spontaneous circulation following cardiac arrest centers on optimizing oxygenation and ventilation, optimizing hemodynamics, identifying patients that require immediate coronary angiography, detecting seizures, and targeted temperature management.Â Â In recent years, numerous articles have evaluated various components of this post-arrest bundle of care.Â Â In the current podcast, we discuss Part II of the BOX Trial that evaluated a restrictive versus liberal oxygenation target in the post-arrest patient.]]></googleplay:description>
	<googleplay:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2022/10/boxtrial.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Does a Higher MAP in the Post-Arrest Patient Make a Difference?</title>
	<link>https://ccpem.blog/podcast/does-a-higher-map-in-the-post-arrest-patient-make-a-difference/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=does-a-higher-map-in-the-post-arrest-patient-make-a-difference&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=does-a-higher-map-in-the-post-arrest-patient-make-a-difference</link>
	<pubDate>Wed, 14 Sep 2022 12:21:26 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1909</guid>
	<description><![CDATA[<p>The care of patients with return of spontaneous circulation following cardiac arrest centers on optimizing oxygenation and ventilation, optimizing hemodynamics, identifying patients that require immediate coronary angiography, detecting seizures, and targeted temperature management.Â Â In recent years, numerous articles have evaluated various components of this post-arrest bundle of care.Â Â In the current podcast, we discuss Part I of the BOX Trial that evaluated mean arterial blood pressures in the post-arrest patient.</p>]]></description>
	<itunes:subtitle><![CDATA[The care of patients with return of spontaneous circulation following cardiac arrest centers on optimizing oxygenation and ventilation, optimizing hemodynamics, identifying patients that require immediate coronary angiography, detecting seizures, and tar]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>The care of patients with return of spontaneous circulation following cardiac arrest centers on optimizing oxygenation and ventilation, optimizing hemodynamics, identifying patients that require immediate coronary angiography, detecting seizures, and targeted temperature management.Â Â In recent years, numerous articles have evaluated various components of this post-arrest bundle of care.Â Â In the current podcast, we discuss Part I of the BOX Trial that evaluated mean arterial blood pressures in the post-arrest patient.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1909/does-a-higher-map-in-the-post-arrest-patient-make-a-difference.mp3" length="37225457" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[The care of patients with return of spontaneous circulation following cardiac arrest centers on optimizing oxygenation and ventilation, optimizing hemodynamics, identifying patients that require immediate coronary angiography, detecting seizures, and targeted temperature management.Â Â In recent years, numerous articles have evaluated various components of this post-arrest bundle of care.Â Â In the current podcast, we discuss Part I of the BOX Trial that evaluated mean arterial blood pressures in the post-arrest patient.]]></itunes:summary>
	<itunes:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2022/09/map.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i1.wp.com/ccpem.blog/wp-content/uploads/2022/09/map.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Does a Higher MAP in the Post-Arrest Patient Make a Difference?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:25:50</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[The care of patients with return of spontaneous circulation following cardiac arrest centers on optimizing oxygenation and ventilation, optimizing hemodynamics, identifying patients that require immediate coronary angiography, detecting seizures, and targeted temperature management.Â Â In recent years, numerous articles have evaluated various components of this post-arrest bundle of care.Â Â In the current podcast, we discuss Part I of the BOX Trial that evaluated mean arterial blood pressures in the post-arrest patient.]]></googleplay:description>
	<googleplay:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2022/09/map.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>IVFs to Prevent Cardiovascular Collapse During RSI &#8211; The PREPARE II Trial</title>
	<link>https://ccpem.blog/podcast/ivfs-to-prevent-cardiovascular-collapse-during-rsi-the-prepare-ii-trial/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=ivfs-to-prevent-cardiovascular-collapse-during-rsi-the-prepare-ii-trial&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=ivfs-to-prevent-cardiovascular-collapse-during-rsi-the-prepare-ii-trial</link>
	<pubDate>Wed, 03 Aug 2022 04:41:08 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1904</guid>
	<description><![CDATA[<p>Approximately 2 million adult patients undergo intubation in the United States each year.Â  Hypotension and cardiovascular collapse may occur in up to 40% of critically ill patients in the ICU who undergo intubation.Â  Guidelines and expert recommendations often suggest the administration of IVFs during RSI to prevent cardiovascular collapse.Â  However, a recent trial found that an IVF bolus during induction did not prevent cardiovascular collapse in a population of critically ill patients.Â  In this podcast, we review and discuss the recently published PREPARE II Trial, which evaluated the administration of IVFs to prevent cardiovascular collapse in critically ill patients undergoing intubation and who were receiving positive pressure ventilation.</p>]]></description>
	<itunes:subtitle><![CDATA[Approximately 2 million adult patients undergo intubation in the United States each year.Â  Hypotension and cardiovascular collapse may occur in up to 40% of critically ill patients in the ICU who undergo intubation.Â  Guidelines and expert recommendatio]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Approximately 2 million adult patients undergo intubation in the United States each year.Â  Hypotension and cardiovascular collapse may occur in up to 40% of critically ill patients in the ICU who undergo intubation.Â  Guidelines and expert recommendations often suggest the administration of IVFs during RSI to prevent cardiovascular collapse.Â  However, a recent trial found that an IVF bolus during induction did not prevent cardiovascular collapse in a population of critically ill patients.Â  In this podcast, we review and discuss the recently published PREPARE II Trial, which evaluated the administration of IVFs to prevent cardiovascular collapse in critically ill patients undergoing intubation and who were receiving positive pressure ventilation.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1904/ivfs-to-prevent-cardiovascular-collapse-during-rsi-the-prepare-ii-trial.mp3" length="27606449" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Approximately 2 million adult patients undergo intubation in the United States each year.Â  Hypotension and cardiovascular collapse may occur in up to 40% of critically ill patients in the ICU who undergo intubation.Â  Guidelines and expert recommendations often suggest the administration of IVFs during RSI to prevent cardiovascular collapse.Â  However, a recent trial found that an IVF bolus during induction did not prevent cardiovascular collapse in a population of critically ill patients.Â  In this podcast, we review and discuss the recently published PREPARE II Trial, which evaluated the administration of IVFs to prevent cardiovascular collapse in critically ill patients undergoing intubation and who were receiving positive pressure ventilation.]]></itunes:summary>
	<itunes:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2022/08/prepare2trial.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i0.wp.com/ccpem.blog/wp-content/uploads/2022/08/prepare2trial.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>IVFs to Prevent Cardiovascular Collapse During RSI &#8211; The PREPARE II Trial</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:19:09</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Approximately 2 million adult patients undergo intubation in the United States each year.Â  Hypotension and cardiovascular collapse may occur in up to 40% of critically ill patients in the ICU who undergo intubation.Â  Guidelines and expert recommendations often suggest the administration of IVFs during RSI to prevent cardiovascular collapse.Â  However, a recent trial found that an IVF bolus during induction did not prevent cardiovascular collapse in a population of critically ill patients.Â  In this podcast, we review and discuss the recently published PREPARE II Trial, which evaluated the administration of IVFs to prevent cardiovascular collapse in critically ill patients undergoing intubation and who were receiving positive pressure ventilation.]]></googleplay:description>
	<googleplay:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2022/08/prepare2trial.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>TAVR Complications You Need to Know!</title>
	<link>https://ccpem.blog/podcast/tavr-complications-you-need-to-know/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=tavr-complications-you-need-to-know&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=tavr-complications-you-need-to-know</link>
	<pubDate>Mon, 18 Jul 2022 13:38:49 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1899</guid>
	<description><![CDATA[<p>Transcatheter aortic valve replacement is now more common than open surgical replacement and may be associated with lower mortality.Â  Given the significant increase in TAVRs it is imperative to be knowledgeable on the complications that may occur following TAVR and result in patients presenting to acute care settings for evaluation and treatment.Â  In this podcast we review an outstanding recent article on TAVR complications and discuss the things we need to know!</p>]]></description>
	<itunes:subtitle><![CDATA[Transcatheter aortic valve replacement is now more common than open surgical replacement and may be associated with lower mortality.Â  Given the significant increase in TAVRs it is imperative to be knowledgeable on the complications that may occur follow]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Transcatheter aortic valve replacement is now more common than open surgical replacement and may be associated with lower mortality.Â  Given the significant increase in TAVRs it is imperative to be knowledgeable on the complications that may occur following TAVR and result in patients presenting to acute care settings for evaluation and treatment.Â  In this podcast we review an outstanding recent article on TAVR complications and discuss the things we need to know!</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1899/tavr-complications-you-need-to-know.mp3" length="39884705" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Transcatheter aortic valve replacement is now more common than open surgical replacement and may be associated with lower mortality.Â  Given the significant increase in TAVRs it is imperative to be knowledgeable on the complications that may occur following TAVR and result in patients presenting to acute care settings for evaluation and treatment.Â  In this podcast we review an outstanding recent article on TAVR complications and discuss the things we need to know!]]></itunes:summary>
	<itunes:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2022/07/tavr.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i1.wp.com/ccpem.blog/wp-content/uploads/2022/07/tavr.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>TAVR Complications You Need to Know!</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:27:41</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Transcatheter aortic valve replacement is now more common than open surgical replacement and may be associated with lower mortality.Â  Given the significant increase in TAVRs it is imperative to be knowledgeable on the complications that may occur following TAVR and result in patients presenting to acute care settings for evaluation and treatment.Â  In this podcast we review an outstanding recent article on TAVR complications and discuss the things we need to know!]]></googleplay:description>
	<googleplay:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2022/07/tavr.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Restrictive Fluid Resuscitation in Sepsis?  The CLASSIC Trial</title>
	<link>https://ccpem.blog/podcast/restrictive-fluid-resuscitation-in-sepsis-the-classic-trial/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=restrictive-fluid-resuscitation-in-sepsis-the-classic-trial&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=restrictive-fluid-resuscitation-in-sepsis-the-classic-trial</link>
	<pubDate>Tue, 05 Jul 2022 12:26:52 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1894</guid>
	<description><![CDATA[<p>IVF administration is central to the management of patients with sepsis.&nbsp; Though the Surviving Sepsis Campaign recently downgraded its recommendation on the amount of initial fluid administration, there are currently no recommendations on a fluid strategy for septic patients who continue to demonstrate hypoperfusion after the initial fluid bolus.&nbsp; In this podcast we discuss the recently published CLASSIC Trial, which compared a restrictive fluid strategy to standard care in adult patients admitted to the ICU with sepsis.</p>]]></description>
	<itunes:subtitle><![CDATA[IVF administration is central to the management of patients with sepsis.&nbsp; Though the Surviving Sepsis Campaign recently downgraded its recommendation on the amount of initial fluid administration, there are currently no recommendations on a fluid st]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>IVF administration is central to the management of patients with sepsis.&nbsp; Though the Surviving Sepsis Campaign recently downgraded its recommendation on the amount of initial fluid administration, there are currently no recommendations on a fluid strategy for septic patients who continue to demonstrate hypoperfusion after the initial fluid bolus.&nbsp; In this podcast we discuss the recently published CLASSIC Trial, which compared a restrictive fluid strategy to standard care in adult patients admitted to the ICU with sepsis.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1894/restrictive-fluid-resuscitation-in-sepsis-the-classic-trial.mp3" length="33046907" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[IVF administration is central to the management of patients with sepsis.&nbsp; Though the Surviving Sepsis Campaign recently downgraded its recommendation on the amount of initial fluid administration, there are currently no recommendations on a fluid strategy for septic patients who continue to demonstrate hypoperfusion after the initial fluid bolus.&nbsp; In this podcast we discuss the recently published CLASSIC Trial, which compared a restrictive fluid strategy to standard care in adult patients admitted to the ICU with sepsis.]]></itunes:summary>
	<itunes:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2022/07/classictrial.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i1.wp.com/ccpem.blog/wp-content/uploads/2022/07/classictrial.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Restrictive Fluid Resuscitation in Sepsis?  The CLASSIC Trial</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:22:56</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[IVF administration is central to the management of patients with sepsis.&nbsp; Though the Surviving Sepsis Campaign recently downgraded its recommendation on the amount of initial fluid administration, there are currently no recommendations on a fluid strategy for septic patients who continue to demonstrate hypoperfusion after the initial fluid bolus.&nbsp; In this podcast we discuss the recently published CLASSIC Trial, which compared a restrictive fluid strategy to standard care in adult patients admitted to the ICU with sepsis.]]></googleplay:description>
	<googleplay:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2022/07/classictrial.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Life-Threatening Asthma</title>
	<link>https://ccpem.blog/podcast/life-threatening-asthma/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=life-threatening-asthma&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=life-threatening-asthma</link>
	<pubDate>Sun, 12 Jun 2022 19:53:40 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1889</guid>
	<description><![CDATA[<p>Approximately 2 million patients present each year to EDs in the United States for acute asthma exacerbations.&nbsp; Of these, up to 50,000 may require ICU admission for continued care and resuscitation.&nbsp; The management of critically ill asthmatic patients can be fraught with peril.&nbsp; In this podcast we discuss the assessment and management of patients presenting with a severe asthma exacerbation.</p>]]></description>
	<itunes:subtitle><![CDATA[Approximately 2 million patients present each year to EDs in the United States for acute asthma exacerbations.&nbsp; Of these, up to 50,000 may require ICU admission for continued care and resuscitation.&nbsp; The management of critically ill asthmatic p]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Approximately 2 million patients present each year to EDs in the United States for acute asthma exacerbations.&nbsp; Of these, up to 50,000 may require ICU admission for continued care and resuscitation.&nbsp; The management of critically ill asthmatic patients can be fraught with peril.&nbsp; In this podcast we discuss the assessment and management of patients presenting with a severe asthma exacerbation.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1889/life-threatening-asthma.mp3" length="53898341" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Approximately 2 million patients present each year to EDs in the United States for acute asthma exacerbations.&nbsp; Of these, up to 50,000 may require ICU admission for continued care and resuscitation.&nbsp; The management of critically ill asthmatic patients can be fraught with peril.&nbsp; In this podcast we discuss the assessment and management of patients presenting with a severe asthma exacerbation.]]></itunes:summary>
	<itunes:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2022/06/asthma.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i0.wp.com/ccpem.blog/wp-content/uploads/2022/06/asthma.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Life-Threatening Asthma</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:37:25</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Approximately 2 million patients present each year to EDs in the United States for acute asthma exacerbations.&nbsp; Of these, up to 50,000 may require ICU admission for continued care and resuscitation.&nbsp; The management of critically ill asthmatic patients can be fraught with peril.&nbsp; In this podcast we discuss the assessment and management of patients presenting with a severe asthma exacerbation.]]></googleplay:description>
	<googleplay:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2022/06/asthma.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Refractory OHCA &#8211; Does ECPR and Early Angiography Improve Outcome?</title>
	<link>https://ccpem.blog/podcast/refractory-ohca-does-ecpr-and-early-angiography-improve-outcome/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=refractory-ohca-does-ecpr-and-early-angiography-improve-outcome&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=refractory-ohca-does-ecpr-and-early-angiography-improve-outcome</link>
	<pubDate>Wed, 18 May 2022 12:41:39 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1881</guid>
	<description><![CDATA[<p>In a recent podcast we reviewed the ARREST Trial,Â which demonstrated significant improvement in survival among OHCA patients at a single center randomized to ECPR and early coronary angiography upon arrival.Â  In this podcast we discuss the latest trial to investigate whether a bundle of early transport, ECPR, and coronary angiography improves favorable neurologic survival in patients with refractory OHCA.</p>]]></description>
	<itunes:subtitle><![CDATA[In a recent podcast we reviewed the ARREST Trial,Â which demonstrated significant improvement in survival among OHCA patients at a single center randomized to ECPR and early coronary angiography upon arrival.Â  In this podcast we discuss the latest trial]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>In a recent podcast we reviewed the ARREST Trial,Â which demonstrated significant improvement in survival among OHCA patients at a single center randomized to ECPR and early coronary angiography upon arrival.Â  In this podcast we discuss the latest trial to investigate whether a bundle of early transport, ECPR, and coronary angiography improves favorable neurologic survival in patients with refractory OHCA.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1881/refractory-ohca-does-ecpr-and-early-angiography-improve-outcome.mp3" length="32860985" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[In a recent podcast we reviewed the ARREST Trial,Â which demonstrated significant improvement in survival among OHCA patients at a single center randomized to ECPR and early coronary angiography upon arrival.Â  In this podcast we discuss the latest trial to investigate whether a bundle of early transport, ECPR, and coronary angiography improves favorable neurologic survival in patients with refractory OHCA.]]></itunes:summary>
	<itunes:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2022/05/refractory.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i1.wp.com/ccpem.blog/wp-content/uploads/2022/05/refractory.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Refractory OHCA &#8211; Does ECPR and Early Angiography Improve Outcome?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:22:48</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[In a recent podcast we reviewed the ARREST Trial,Â which demonstrated significant improvement in survival among OHCA patients at a single center randomized to ECPR and early coronary angiography upon arrival.Â  In this podcast we discuss the latest trial to investigate whether a bundle of early transport, ECPR, and coronary angiography improves favorable neurologic survival in patients with refractory OHCA.]]></googleplay:description>
	<googleplay:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2022/05/refractory.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Low-Tidal Volume Ventilation in the ED &#8211; Does it Make a Difference?</title>
	<link>https://ccpem.blog/podcast/low-tidal-volume-ventilation-in-the-ed-does-it-make-a-difference/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=low-tidal-volume-ventilation-in-the-ed-does-it-make-a-difference&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=low-tidal-volume-ventilation-in-the-ed-does-it-make-a-difference</link>
	<pubDate>Wed, 20 Apr 2022 20:49:45 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1876</guid>
	<description><![CDATA[<p>Though low-tidal volume ventilation has been shown to decreased mortality in patients with ARDS, the use of these settings in mechanically ventilated ED patients has been variable.Â  In this podcast, we discuss a recent systematic review that examined the effect of low-tidal volume ventilation in the ED on clinical outcomes including mortality, length of stay, occurrence of ARDS, and duration of mechanical ventilation.</p>]]></description>
	<itunes:subtitle><![CDATA[Though low-tidal volume ventilation has been shown to decreased mortality in patients with ARDS, the use of these settings in mechanically ventilated ED patients has been variable.Â  In this podcast, we discuss a recent systematic review that examined th]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Though low-tidal volume ventilation has been shown to decreased mortality in patients with ARDS, the use of these settings in mechanically ventilated ED patients has been variable.Â  In this podcast, we discuss a recent systematic review that examined the effect of low-tidal volume ventilation in the ED on clinical outcomes including mortality, length of stay, occurrence of ARDS, and duration of mechanical ventilation.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1876/low-tidal-volume-ventilation-in-the-ed-does-it-make-a-difference.mp3" length="30207371" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Though low-tidal volume ventilation has been shown to decreased mortality in patients with ARDS, the use of these settings in mechanically ventilated ED patients has been variable.Â  In this podcast, we discuss a recent systematic review that examined the effect of low-tidal volume ventilation in the ED on clinical outcomes including mortality, length of stay, occurrence of ARDS, and duration of mechanical ventilation.]]></itunes:summary>
	<itunes:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2022/04/low-tidal.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i1.wp.com/ccpem.blog/wp-content/uploads/2022/04/low-tidal.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Low-Tidal Volume Ventilation in the ED &#8211; Does it Make a Difference?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:20:58</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Though low-tidal volume ventilation has been shown to decreased mortality in patients with ARDS, the use of these settings in mechanically ventilated ED patients has been variable.Â  In this podcast, we discuss a recent systematic review that examined the effect of low-tidal volume ventilation in the ED on clinical outcomes including mortality, length of stay, occurrence of ARDS, and duration of mechanical ventilation.]]></googleplay:description>
	<googleplay:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2022/04/low-tidal.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>The PLUS Study</title>
	<link>https://ccpem.blog/podcast/the-plus-study/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-plus-study&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-plus-study</link>
	<pubDate>Tue, 29 Mar 2022 12:57:39 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1870</guid>
	<description><![CDATA[<p>Though we've discussed the use of balanced solutions in the resuscitation of critically ill patients numerous times on CCPEM, the literature remains controversial with mixed results as to which IVFs are superior.&nbsp; In this podcast, we discuss the latest randomized trial, the PLUS Study, comparing the use of balanced multielectrolyte solution and 0.9% normal saline.</p>]]></description>
	<itunes:subtitle><![CDATA[Though weve discussed the use of balanced solutions in the resuscitation of critically ill patients numerous times on CCPEM, the literature remains controversial with mixed results as to which IVFs are superior.&nbsp; In this podcast, we discuss the late]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Though we've discussed the use of balanced solutions in the resuscitation of critically ill patients numerous times on CCPEM, the literature remains controversial with mixed results as to which IVFs are superior.&nbsp; In this podcast, we discuss the latest randomized trial, the PLUS Study, comparing the use of balanced multielectrolyte solution and 0.9% normal saline.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1870/the-plus-study.mp3" length="30026457" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Though we've discussed the use of balanced solutions in the resuscitation of critically ill patients numerous times on CCPEM, the literature remains controversial with mixed results as to which IVFs are superior.&nbsp; In this podcast, we discuss the latest randomized trial, the PLUS Study, comparing the use of balanced multielectrolyte solution and 0.9% normal saline.]]></itunes:summary>
	<itunes:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2022/03/plusstudy.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i0.wp.com/ccpem.blog/wp-content/uploads/2022/03/plusstudy.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>The PLUS Study</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:20:50</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Though we've discussed the use of balanced solutions in the resuscitation of critically ill patients numerous times on CCPEM, the literature remains controversial with mixed results as to which IVFs are superior.&nbsp; In this podcast, we discuss the latest randomized trial, the PLUS Study, comparing the use of balanced multielectrolyte solution and 0.9% normal saline.]]></googleplay:description>
	<googleplay:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2022/03/plusstudy.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>The Critically Ill Patient with HHS</title>
	<link>https://ccpem.blog/podcast/the-critically-ill-patient-with-hhs/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-critically-ill-patient-with-hhs&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-critically-ill-patient-with-hhs</link>
	<pubDate>Tue, 08 Mar 2022 16:50:44 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1864</guid>
	<description><![CDATA[<p>Hyperglycemic hyperosmolar syndrome (HHS) is a potentially life-threatening hyperglycemic emergency that has a mortality that can be 10 times as high compared with patients who have diabetic ketoacidosis. Resuscitation of these complex patients can be fraught with peril and result in patient harm and poor outcomes.&nbsp;&nbsp;In this podcast, we discuss the identification and resuscitation of patients with HHS.</p>]]></description>
	<itunes:subtitle><![CDATA[Hyperglycemic hyperosmolar syndrome (HHS) is a potentially life-threatening hyperglycemic emergency that has a mortality that can be 10 times as high compared with patients who have diabetic ketoacidosis. Resuscitation of these complex patients can be fr]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Hyperglycemic hyperosmolar syndrome (HHS) is a potentially life-threatening hyperglycemic emergency that has a mortality that can be 10 times as high compared with patients who have diabetic ketoacidosis. Resuscitation of these complex patients can be fraught with peril and result in patient harm and poor outcomes.&nbsp;&nbsp;In this podcast, we discuss the identification and resuscitation of patients with HHS.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1864/the-critically-ill-patient-with-hhs.mp3" length="44060125" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Hyperglycemic hyperosmolar syndrome (HHS) is a potentially life-threatening hyperglycemic emergency that has a mortality that can be 10 times as high compared with patients who have diabetic ketoacidosis. Resuscitation of these complex patients can be fraught with peril and result in patient harm and poor outcomes.&nbsp;&nbsp;In this podcast, we discuss the identification and resuscitation of patients with HHS.]]></itunes:summary>
	<itunes:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2022/03/hhs.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i0.wp.com/ccpem.blog/wp-content/uploads/2022/03/hhs.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>The Critically Ill Patient with HHS</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:30:35</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Hyperglycemic hyperosmolar syndrome (HHS) is a potentially life-threatening hyperglycemic emergency that has a mortality that can be 10 times as high compared with patients who have diabetic ketoacidosis. Resuscitation of these complex patients can be fraught with peril and result in patient harm and poor outcomes.&nbsp;&nbsp;In this podcast, we discuss the identification and resuscitation of patients with HHS.]]></googleplay:description>
	<googleplay:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2022/03/hhs.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Ketamine or Etomidate for RSI?</title>
	<link>https://ccpem.blog/podcast/ketamine-or-etomidate-for-rsi/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=ketamine-or-etomidate-for-rsi&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=ketamine-or-etomidate-for-rsi</link>
	<pubDate>Mon, 21 Feb 2022 16:24:06 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1859</guid>
	<description><![CDATA[<p>Etomidate and ketamine are frequently used for RSI in critically ill patients.Â  Recent articles have raised concern about an increased incidence of post-intubation hypotension in patients who receive ketamine for RSI.Â  Notwithstanding, is either agent superior for RSI in the critically ill?Â  In this podcast we discuss the recently published EvK trial, which evaluated etomidate and ketamine for RSI in emergency endotracheal intubations.</p>]]></description>
	<itunes:subtitle><![CDATA[Etomidate and ketamine are frequently used for RSI in critically ill patients.Â  Recent articles have raised concern about an increased incidence of post-intubation hypotension in patients who receive ketamine for RSI.Â  Notwithstanding, is either agent ]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Etomidate and ketamine are frequently used for RSI in critically ill patients.Â  Recent articles have raised concern about an increased incidence of post-intubation hypotension in patients who receive ketamine for RSI.Â  Notwithstanding, is either agent superior for RSI in the critically ill?Â  In this podcast we discuss the recently published EvK trial, which evaluated etomidate and ketamine for RSI in emergency endotracheal intubations.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1859/ketamine-or-etomidate-for-rsi.mp3" length="34598129" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Etomidate and ketamine are frequently used for RSI in critically ill patients.Â  Recent articles have raised concern about an increased incidence of post-intubation hypotension in patients who receive ketamine for RSI.Â  Notwithstanding, is either agent superior for RSI in the critically ill?Â  In this podcast we discuss the recently published EvK trial, which evaluated etomidate and ketamine for RSI in emergency endotracheal intubations.]]></itunes:summary>
	<itunes:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2022/02/ketaminevs.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i1.wp.com/ccpem.blog/wp-content/uploads/2022/02/ketaminevs.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Ketamine or Etomidate for RSI?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:24:01</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Etomidate and ketamine are frequently used for RSI in critically ill patients.Â  Recent articles have raised concern about an increased incidence of post-intubation hypotension in patients who receive ketamine for RSI.Â  Notwithstanding, is either agent superior for RSI in the critically ill?Â  In this podcast we discuss the recently published EvK trial, which evaluated etomidate and ketamine for RSI in emergency endotracheal intubations.]]></googleplay:description>
	<googleplay:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2022/02/ketaminevs.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>The 2021 Critical Care Literature &#8211; A Year in Review</title>
	<link>https://ccpem.blog/podcast/the-2021-critical-care-literature-a-year-in-review/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-2021-critical-care-literature-a-year-in-review&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-2021-critical-care-literature-a-year-in-review</link>
	<pubDate>Wed, 09 Feb 2022 15:44:39 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1854</guid>
	<description><![CDATA[<p>While COVID continued to be predominant in 2021, a number of important articles that pertained to various aspects of critical care and resuscitation were published.Â  In this podcast, we review a few important trials that were published in 2021 and their impact upon the management of select critical illnesses.</p>]]></description>
	<itunes:subtitle><![CDATA[While COVID continued to be predominant in 2021, a number of important articles that pertained to various aspects of critical care and resuscitation were published.Â  In this podcast, we review a few important trials that were published in 2021 and their]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>While COVID continued to be predominant in 2021, a number of important articles that pertained to various aspects of critical care and resuscitation were published.Â  In this podcast, we review a few important trials that were published in 2021 and their impact upon the management of select critical illnesses.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1854/the-2021-critical-care-literature-a-year-in-review.mp3" length="78060689" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[While COVID continued to be predominant in 2021, a number of important articles that pertained to various aspects of critical care and resuscitation were published.Â  In this podcast, we review a few important trials that were published in 2021 and their impact upon the management of select critical illnesses.]]></itunes:summary>
	<itunes:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2022/02/2021review.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i0.wp.com/ccpem.blog/wp-content/uploads/2022/02/2021review.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>The 2021 Critical Care Literature &#8211; A Year in Review</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:54:12</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[While COVID continued to be predominant in 2021, a number of important articles that pertained to various aspects of critical care and resuscitation were published.Â  In this podcast, we review a few important trials that were published in 2021 and their impact upon the management of select critical illnesses.]]></googleplay:description>
	<googleplay:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2022/02/2021review.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>EM-STAT!</title>
	<link>https://ccpem.blog/podcast/em-stat/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=em-stat&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=em-stat</link>
	<pubDate>Mon, 31 Jan 2022 14:00:54 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1849</guid>
	<description><![CDATA[<p>Resuscitating the sick patient and providing ongoing critical care is incredibly challenging in critical access locations and resource limited EDs.&nbsp; In this podcast, we interview Dr. Eric Klotz who has runs a hugely successful mobile critical care team that provides ongoing critical care and resuscitation to patients requiring transfer from resource limited settings.</p>]]></description>
	<itunes:subtitle><![CDATA[Resuscitating the sick patient and providing ongoing critical care is incredibly challenging in critical access locations and resource limited EDs.&nbsp; In this podcast, we interview Dr. Eric Klotz who has runs a hugely successful mobile critical care t]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Resuscitating the sick patient and providing ongoing critical care is incredibly challenging in critical access locations and resource limited EDs.&nbsp; In this podcast, we interview Dr. Eric Klotz who has runs a hugely successful mobile critical care team that provides ongoing critical care and resuscitation to patients requiring transfer from resource limited settings.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1849/em-stat.mp3" length="29289763" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Resuscitating the sick patient and providing ongoing critical care is incredibly challenging in critical access locations and resource limited EDs.&nbsp; In this podcast, we interview Dr. Eric Klotz who has runs a hugely successful mobile critical care team that provides ongoing critical care and resuscitation to patients requiring transfer from resource limited settings.]]></itunes:summary>
	<itunes:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2022/01/emstat.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i1.wp.com/ccpem.blog/wp-content/uploads/2022/01/emstat.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>EM-STAT!</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:20:19</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Resuscitating the sick patient and providing ongoing critical care is incredibly challenging in critical access locations and resource limited EDs.&nbsp; In this podcast, we interview Dr. Eric Klotz who has runs a hugely successful mobile critical care team that provides ongoing critical care and resuscitation to patients requiring transfer from resource limited settings.]]></googleplay:description>
	<googleplay:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2022/01/emstat.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Bicarbonate Therapy in the Critically Ill Patient</title>
	<link>https://ccpem.blog/podcast/bicarbonate-therapy-in-the-critically-ill-patient/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=bicarbonate-therapy-in-the-critically-ill-patient&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=bicarbonate-therapy-in-the-critically-ill-patient</link>
	<pubDate>Thu, 20 Jan 2022 16:15:15 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1844</guid>
	<description><![CDATA[<p>In this podcast we are joined by EM/CCM superstars Dr. Gabe Wardi and Dr. Kit Tainter, who discuss the physiologic effects of metabolic acidosis, the rationale for sodium bicarbonate administration, and its use in select critical illness states.&nbsp; An awesome podcast to start of 2022!</p>]]></description>
	<itunes:subtitle><![CDATA[In this podcast we are joined by EM/CCM superstars Dr. Gabe Wardi and Dr. Kit Tainter, who discuss the physiologic effects of metabolic acidosis, the rationale for sodium bicarbonate administration, and its use in select critical illness states.&nbsp; An]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>In this podcast we are joined by EM/CCM superstars Dr. Gabe Wardi and Dr. Kit Tainter, who discuss the physiologic effects of metabolic acidosis, the rationale for sodium bicarbonate administration, and its use in select critical illness states.&nbsp; An awesome podcast to start of 2022!</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1844/bicarbonate-therapy-in-the-critically-ill-patient.mp3" length="59988803" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[In this podcast we are joined by EM/CCM superstars Dr. Gabe Wardi and Dr. Kit Tainter, who discuss the physiologic effects of metabolic acidosis, the rationale for sodium bicarbonate administration, and its use in select critical illness states.&nbsp; An awesome podcast to start of 2022!]]></itunes:summary>
	<itunes:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2022/01/bicarbonate.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i0.wp.com/ccpem.blog/wp-content/uploads/2022/01/bicarbonate.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Bicarbonate Therapy in the Critically Ill Patient</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:41:39</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[In this podcast we are joined by EM/CCM superstars Dr. Gabe Wardi and Dr. Kit Tainter, who discuss the physiologic effects of metabolic acidosis, the rationale for sodium bicarbonate administration, and its use in select critical illness states.&nbsp; An awesome podcast to start of 2022!]]></googleplay:description>
	<googleplay:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2022/01/bicarbonate.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>The BOUGIE Trial</title>
	<link>https://ccpem.blog/podcast/the-bougie-trial/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-bougie-trial&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-bougie-trial</link>
	<pubDate>Tue, 28 Dec 2021 18:30:24 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1839</guid>
	<description><![CDATA[<p>More than 1.5 million patients are intubated each year in the United States.&nbsp;&nbsp;In up to 20% of patients, the first attempt at intubation is not successful and places patients at risk for peri-intubation cardiovascular collapse and death.&nbsp;&nbsp;In recent years, many providers have used the bougie as either a rescue device for failed attempts or during the initial attempt at intubation.&nbsp;&nbsp;In this podcast, we discuss the BOUGIE Trial, a recently published study that compared the effect of using a bougie to endotracheal tube with stylet on outcomes in patients undergoing tracheal intubation.ReplyReply allForward</p>]]></description>
	<itunes:subtitle><![CDATA[More than 1.5 million patients are intubated each year in the United States.&nbsp;&nbsp;In up to 20% of patients, the first attempt at intubation is not successful and places patients at risk for peri-intubation cardiovascular collapse and death.&nbsp;&n]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>More than 1.5 million patients are intubated each year in the United States.&nbsp;&nbsp;In up to 20% of patients, the first attempt at intubation is not successful and places patients at risk for peri-intubation cardiovascular collapse and death.&nbsp;&nbsp;In recent years, many providers have used the bougie as either a rescue device for failed attempts or during the initial attempt at intubation.&nbsp;&nbsp;In this podcast, we discuss the BOUGIE Trial, a recently published study that compared the effect of using a bougie to endotracheal tube with stylet on outcomes in patients undergoing tracheal intubation.ReplyReply allForward</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1839/the-bougie-trial.mp3" length="36048577" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[More than 1.5 million patients are intubated each year in the United States.&nbsp;&nbsp;In up to 20% of patients, the first attempt at intubation is not successful and places patients at risk for peri-intubation cardiovascular collapse and death.&nbsp;&nbsp;In recent years, many providers have used the bougie as either a rescue device for failed attempts or during the initial attempt at intubation.&nbsp;&nbsp;In this podcast, we discuss the BOUGIE Trial, a recently published study that compared the effect of using a bougie to endotracheal tube with stylet on outcomes in patients undergoing tracheal intubation.ReplyReply allForward]]></itunes:summary>
	<itunes:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2021/12/bougie.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i2.wp.com/ccpem.blog/wp-content/uploads/2021/12/bougie.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>The BOUGIE Trial</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:25:01</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[More than 1.5 million patients are intubated each year in the United States.&nbsp;&nbsp;In up to 20% of patients, the first attempt at intubation is not successful and places patients at risk for peri-intubation cardiovascular collapse and death.&nbsp;&nbsp;In recent years, many providers have used the bougie as either a rescue device for failed attempts or during the initial attempt at intubation.&nbsp;&nbsp;In this podcast, we discuss the BOUGIE Trial, a recently published study that compared the effect of using a bougie to endotracheal tube with stylet on outcomes in patients undergoing tracheal intubation.ReplyReply allForward]]></googleplay:description>
	<googleplay:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2021/12/bougie.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>MIS-C in COVID-19</title>
	<link>https://ccpem.blog/podcast/mis-c-in-covid-19/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=mis-c-in-covid-19&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=mis-c-in-covid-19</link>
	<pubDate>Thu, 02 Dec 2021 18:10:27 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1833</guid>
	<description><![CDATA[<p>The COVID-19 pandemic continues to affect millions of patients worldwide.Â Â While the majority of children have milder illness compared with adults, some develop multisystem inflammatory syndrome with a significant increase in morbidity and mortality.Â Â In this podcast, we discuss a recent review article on MIS-C as it pertains to the pediatric patient with COVID-19. </p>]]></description>
	<itunes:subtitle><![CDATA[The COVID-19 pandemic continues to affect millions of patients worldwide.Â Â While the majority of children have milder illness compared with adults, some develop multisystem inflammatory syndrome with a significant increase in morbidity and mortality.Â ]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>The COVID-19 pandemic continues to affect millions of patients worldwide.Â Â While the majority of children have milder illness compared with adults, some develop multisystem inflammatory syndrome with a significant increase in morbidity and mortality.Â Â In this podcast, we discuss a recent review article on MIS-C as it pertains to the pediatric patient with COVID-19. </p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1833/mis-c-in-covid-19.mp3" length="32358933" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[The COVID-19 pandemic continues to affect millions of patients worldwide.Â Â While the majority of children have milder illness compared with adults, some develop multisystem inflammatory syndrome with a significant increase in morbidity and mortality.Â Â In this podcast, we discuss a recent review article on MIS-C as it pertains to the pediatric patient with COVID-19.]]></itunes:summary>
	<itunes:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2021/12/mis-c.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i0.wp.com/ccpem.blog/wp-content/uploads/2021/12/mis-c.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>MIS-C in COVID-19</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:22:27</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[The COVID-19 pandemic continues to affect millions of patients worldwide.Â Â While the majority of children have milder illness compared with adults, some develop multisystem inflammatory syndrome with a significant increase in morbidity and mortality.Â Â In this podcast, we discuss a recent review article on MIS-C as it pertains to the pediatric patient with COVID-19.]]></googleplay:description>
	<googleplay:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2021/12/mis-c.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Hyperkalemia in the ED</title>
	<link>https://ccpem.blog/podcast/hyperkalemia-in-the-ed/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=hyperkalemia-in-the-ed&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=hyperkalemia-in-the-ed</link>
	<pubDate>Wed, 10 Nov 2021 19:16:30 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1824</guid>
	<description><![CDATA[<p>Hyperkalemia is a life-threatening electrolyte disorder that is commonly encountered in the ED and ICU.&nbsp; In this podcast we review the latest evidence in the management&nbsp;of hyperkalemia based on a recently published consensus-based panel. https://ccpem.blog/wp-content/uploads/2021/11/CCPEM-Hyperkalemia-in-the-Emergency-Department.pdf</p>]]></description>
	<itunes:subtitle><![CDATA[Hyperkalemia is a life-threatening electrolyte disorder that is commonly encountered in the ED and ICU.&nbsp; In this podcast we review the latest evidence in the management&nbsp;of hyperkalemia based on a recently published consensus-based panel. https:]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Hyperkalemia is a life-threatening electrolyte disorder that is commonly encountered in the ED and ICU.&nbsp; In this podcast we review the latest evidence in the management&nbsp;of hyperkalemia based on a recently published consensus-based panel. https://ccpem.blog/wp-content/uploads/2021/11/CCPEM-Hyperkalemia-in-the-Emergency-Department.pdf</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1824/hyperkalemia-in-the-ed.mp3" length="41040922" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Hyperkalemia is a life-threatening electrolyte disorder that is commonly encountered in the ED and ICU.&nbsp; In this podcast we review the latest evidence in the management&nbsp;of hyperkalemia based on a recently published consensus-based panel. https://ccpem.blog/wp-content/uploads/2021/11/CCPEM-Hyperkalemia-in-the-Emergency-Department.pdf]]></itunes:summary>
	<itunes:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2021/11/hyperkalemia.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i2.wp.com/ccpem.blog/wp-content/uploads/2021/11/hyperkalemia.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Hyperkalemia in the ED</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:28:29</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Hyperkalemia is a life-threatening electrolyte disorder that is commonly encountered in the ED and ICU.&nbsp; In this podcast we review the latest evidence in the management&nbsp;of hyperkalemia based on a recently published consensus-based panel. https://ccpem.blog/wp-content/uploads/2021/11/CCPEM-Hyperkalemia-in-the-Emergency-Department.pdf]]></googleplay:description>
	<googleplay:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2021/11/hyperkalemia.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Vasopressin and Steroids for IHCA?</title>
	<link>https://ccpem.blog/podcast/vasopressin-and-steroids-for-ihca/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=vasopressin-and-steroids-for-ihca&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=vasopressin-and-steroids-for-ihca</link>
	<pubDate>Mon, 25 Oct 2021 16:10:46 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1793</guid>
	<description><![CDATA[<p>In 2009 and 2013 investigators published studies that demonstrated improved outcomes in patients with IHCA who received vasopressin and steroids in addition to epinephrine.Â  However, both US and European cardiac arrest guidelines have not endorsed these medications due to lack of additional evidence.Â  In this podcast we discuss the recently published VAM-IHCA trial, which evaluated vasopressin and steroids for patients with IHCA.Â  Should we now be administering this combination of medications along with epinephrine for IHCA?Â   </p>]]></description>
	<itunes:subtitle><![CDATA[In 2009 and 2013 investigators published studies that demonstrated improved outcomes in patients with IHCA who received vasopressin and steroids in addition to epinephrine.Â  However, both US and European cardiac arrest guidelines have not endorsed these]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>In 2009 and 2013 investigators published studies that demonstrated improved outcomes in patients with IHCA who received vasopressin and steroids in addition to epinephrine.Â  However, both US and European cardiac arrest guidelines have not endorsed these medications due to lack of additional evidence.Â  In this podcast we discuss the recently published VAM-IHCA trial, which evaluated vasopressin and steroids for patients with IHCA.Â  Should we now be administering this combination of medications along with epinephrine for IHCA?Â   </p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1793/vasopressin-and-steroids-for-ihca.mp3" length="38421743" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[In 2009 and 2013 investigators published studies that demonstrated improved outcomes in patients with IHCA who received vasopressin and steroids in addition to epinephrine.Â  However, both US and European cardiac arrest guidelines have not endorsed these medications due to lack of additional evidence.Â  In this podcast we discuss the recently published VAM-IHCA trial, which evaluated vasopressin and steroids for patients with IHCA.Â  Should we now be administering this combination of medications along with epinephrine for IHCA?Â ]]></itunes:summary>
	<itunes:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2021/10/vaso.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i1.wp.com/ccpem.blog/wp-content/uploads/2021/10/vaso.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Vasopressin and Steroids for IHCA?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:26:40</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[In 2009 and 2013 investigators published studies that demonstrated improved outcomes in patients with IHCA who received vasopressin and steroids in addition to epinephrine.Â  However, both US and European cardiac arrest guidelines have not endorsed these medications due to lack of additional evidence.Â  In this podcast we discuss the recently published VAM-IHCA trial, which evaluated vasopressin and steroids for patients with IHCA.Â  Should we now be administering this combination of medications along with epinephrine for IHCA?Â ]]></googleplay:description>
	<googleplay:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2021/10/vaso.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Milrinone or Dobutamine for Cardiogenic Shock?</title>
	<link>https://ccpem.blog/podcast/milrinone-or-dobutamine-for-cardiogenic-shock/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=milrinone-or-dobutamine-for-cardiogenic-shock&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=milrinone-or-dobutamine-for-cardiogenic-shock</link>
	<pubDate>Mon, 27 Sep 2021 13:56:20 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1729</guid>
	<description><![CDATA[<p>Hemodynamic management of patients with cardiogenic shock centers on vasopressors, inotropes, and mechanical circulatory devices.Â  With respect to inotropic medications, there is little data to guide optimal management and selection of agents.Â  In this podcast we discuss the results of a recent trial that compared milrinone with dobutamine for patients with cardiogenic shock.Â  Which agent was the winner?</p>]]></description>
	<itunes:subtitle><![CDATA[Hemodynamic management of patients with cardiogenic shock centers on vasopressors, inotropes, and mechanical circulatory devices.Â  With respect to inotropic medications, there is little data to guide optimal management and selection of agents.Â  In this]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Hemodynamic management of patients with cardiogenic shock centers on vasopressors, inotropes, and mechanical circulatory devices.Â  With respect to inotropic medications, there is little data to guide optimal management and selection of agents.Â  In this podcast we discuss the results of a recent trial that compared milrinone with dobutamine for patients with cardiogenic shock.Â  Which agent was the winner?</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1729/milrinone-or-dobutamine-for-cardiogenic-shock.mp3" length="36980691" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Hemodynamic management of patients with cardiogenic shock centers on vasopressors, inotropes, and mechanical circulatory devices.Â  With respect to inotropic medications, there is little data to guide optimal management and selection of agents.Â  In this podcast we discuss the results of a recent trial that compared milrinone with dobutamine for patients with cardiogenic shock.Â  Which agent was the winner?]]></itunes:summary>
	<itunes:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2021/09/cardiogenicshock.png?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i2.wp.com/ccpem.blog/wp-content/uploads/2021/09/cardiogenicshock.png?fit=1000%2C300&#038;ssl=1</url>
		<title>Milrinone or Dobutamine for Cardiogenic Shock?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:25:40</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Hemodynamic management of patients with cardiogenic shock centers on vasopressors, inotropes, and mechanical circulatory devices.Â  With respect to inotropic medications, there is little data to guide optimal management and selection of agents.Â  In this podcast we discuss the results of a recent trial that compared milrinone with dobutamine for patients with cardiogenic shock.Â  Which agent was the winner?]]></googleplay:description>
	<googleplay:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2021/09/cardiogenicshock.png?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>The TOMAHAWK Study</title>
	<link>https://ccpem.blog/podcast/the-tomahawk-study/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-tomahawk-study&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-tomahawk-study</link>
	<pubDate>Thu, 16 Sep 2021 19:25:50 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1695</guid>
	<description><![CDATA[<p>The COACT trial demonstrated no improvement in 90-day mortality for post-arrest patients without evidence of an ST-segment elevation MI who were randomized to immediate or delayed coronary angiography.Â  However, the COACT Trial included only OHCA with a shockable rhythm and overall had a very low number of patients that had an acute thrombus at the time of angiography.Â  In this podcast, we discuss the recently published TOMAHAWK study that evaluated OHCA patients due to either a shockable or nonshockable rhythm and had no evidence of a STEMI.Â  Should this study change our post-arrest management of OHCA patients with a non-diagnostic ECG?</p>]]></description>
	<itunes:subtitle><![CDATA[The COACT trial demonstrated no improvement in 90-day mortality for post-arrest patients without evidence of an ST-segment elevation MI who were randomized to immediate or delayed coronary angiography.Â  However, the COACT Trial included only OHCA with a]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>The COACT trial demonstrated no improvement in 90-day mortality for post-arrest patients without evidence of an ST-segment elevation MI who were randomized to immediate or delayed coronary angiography.Â  However, the COACT Trial included only OHCA with a shockable rhythm and overall had a very low number of patients that had an acute thrombus at the time of angiography.Â  In this podcast, we discuss the recently published TOMAHAWK study that evaluated OHCA patients due to either a shockable or nonshockable rhythm and had no evidence of a STEMI.Â  Should this study change our post-arrest management of OHCA patients with a non-diagnostic ECG?</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1695/the-tomahawk-study.mp3" length="42209669" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[The COACT trial demonstrated no improvement in 90-day mortality for post-arrest patients without evidence of an ST-segment elevation MI who were randomized to immediate or delayed coronary angiography.Â  However, the COACT Trial included only OHCA with a shockable rhythm and overall had a very low number of patients that had an acute thrombus at the time of angiography.Â  In this podcast, we discuss the recently published TOMAHAWK study that evaluated OHCA patients due to either a shockable or nonshockable rhythm and had no evidence of a STEMI.Â  Should this study change our post-arrest management of OHCA patients with a non-diagnostic ECG?]]></itunes:summary>
	<itunes:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2021/09/tomahawk.png?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i1.wp.com/ccpem.blog/wp-content/uploads/2021/09/tomahawk.png?fit=1000%2C300&#038;ssl=1</url>
		<title>The TOMAHAWK Study</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:29:18</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[The COACT trial demonstrated no improvement in 90-day mortality for post-arrest patients without evidence of an ST-segment elevation MI who were randomized to immediate or delayed coronary angiography.Â  However, the COACT Trial included only OHCA with a shockable rhythm and overall had a very low number of patients that had an acute thrombus at the time of angiography.Â  In this podcast, we discuss the recently published TOMAHAWK study that evaluated OHCA patients due to either a shockable or nonshockable rhythm and had no evidence of a STEMI.Â  Should this study change our post-arrest management of OHCA patients with a non-diagnostic ECG?]]></googleplay:description>
	<googleplay:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2021/09/tomahawk.png?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>The BaSICS Trial &#8211; Implications for Fluid Resuscitation</title>
	<link>https://ccpem.blog/podcast/the-basics-trial-implications-for-fluid-resuscitation/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-basics-trial-implications-for-fluid-resuscitation&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-basics-trial-implications-for-fluid-resuscitation</link>
	<pubDate>Sun, 29 Aug 2021 12:20:30 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1652</guid>
	<description><![CDATA[<p>The administration of IVFs is nearly universal in critically ill patients.&nbsp; In recent years, several studies have suggested improved outcomes with the use of balanced crystalloids solutions in contrast to 0.9% NS.&nbsp; In this podcast, we discuss the recently published BaSICS Trial that evaluated Plasma-Lyte 148 with 0.9% NS in critically ill patients.&nbsp; Does this study provide practice-changing evidence to make that switch?</p>]]></description>
	<itunes:subtitle><![CDATA[The administration of IVFs is nearly universal in critically ill patients.&nbsp; In recent years, several studies have suggested improved outcomes with the use of balanced crystalloids solutions in contrast to 0.9% NS.&nbsp; In this podcast, we discuss t]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>The administration of IVFs is nearly universal in critically ill patients.&nbsp; In recent years, several studies have suggested improved outcomes with the use of balanced crystalloids solutions in contrast to 0.9% NS.&nbsp; In this podcast, we discuss the recently published BaSICS Trial that evaluated Plasma-Lyte 148 with 0.9% NS in critically ill patients.&nbsp; Does this study provide practice-changing evidence to make that switch?</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1652/the-basics-trial-implications-for-fluid-resuscitation.mp3" length="31783747" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[The administration of IVFs is nearly universal in critically ill patients.&nbsp; In recent years, several studies have suggested improved outcomes with the use of balanced crystalloids solutions in contrast to 0.9% NS.&nbsp; In this podcast, we discuss the recently published BaSICS Trial that evaluated Plasma-Lyte 148 with 0.9% NS in critically ill patients.&nbsp; Does this study provide practice-changing evidence to make that switch?]]></itunes:summary>
	<itunes:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2021/08/basics2.png?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i0.wp.com/ccpem.blog/wp-content/uploads/2021/08/basics2.png?fit=1000%2C300&#038;ssl=1</url>
		<title>The BaSICS Trial &#8211; Implications for Fluid Resuscitation</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:22:03</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[The administration of IVFs is nearly universal in critically ill patients.&nbsp; In recent years, several studies have suggested improved outcomes with the use of balanced crystalloids solutions in contrast to 0.9% NS.&nbsp; In this podcast, we discuss the recently published BaSICS Trial that evaluated Plasma-Lyte 148 with 0.9% NS in critically ill patients.&nbsp; Does this study provide practice-changing evidence to make that switch?]]></googleplay:description>
	<googleplay:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2021/08/basics2.png?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Pigtail Catheters for Traumatic Hemothorax?</title>
	<link>https://ccpem.blog/podcast/pigtail-catheters-for-traumatic-hemothorax/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=pigtail-catheters-for-traumatic-hemothorax&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=pigtail-catheters-for-traumatic-hemothorax</link>
	<pubDate>Thu, 05 Aug 2021 20:08:58 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">http://ccpem.blog/?post_type=podcast&#038;p=1605</guid>
	<description><![CDATA[<p>Traumatic hemothorax has traditionally been treated with a large bore thoracostomy to prevent retained hemothorax and morbidity.&nbsp; In this podcast we discuss the results of a recent study on the use of small bore thoracostomy (pigtail catheters) for the treatment of traumatic hemothorax.</p>]]></description>
	<itunes:subtitle><![CDATA[Traumatic hemothorax has traditionally been treated with a large bore thoracostomy to prevent retained hemothorax and morbidity.&nbsp; In this podcast we discuss the results of a recent study on the use of small bore thoracostomy (pigtail catheters) for ]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Traumatic hemothorax has traditionally been treated with a large bore thoracostomy to prevent retained hemothorax and morbidity.&nbsp; In this podcast we discuss the results of a recent study on the use of small bore thoracostomy (pigtail catheters) for the treatment of traumatic hemothorax.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1605/pigtail-catheters-for-traumatic-hemothorax.mp3" length="34494219" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Traumatic hemothorax has traditionally been treated with a large bore thoracostomy to prevent retained hemothorax and morbidity.&nbsp; In this podcast we discuss the results of a recent study on the use of small bore thoracostomy (pigtail catheters) for the treatment of traumatic hemothorax.]]></itunes:summary>
	<itunes:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2021/08/pigtail.png?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i0.wp.com/ccpem.blog/wp-content/uploads/2021/08/pigtail.png?fit=1000%2C300&#038;ssl=1</url>
		<title>Pigtail Catheters for Traumatic Hemothorax?</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:23:56</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Traumatic hemothorax has traditionally been treated with a large bore thoracostomy to prevent retained hemothorax and morbidity.&nbsp; In this podcast we discuss the results of a recent study on the use of small bore thoracostomy (pigtail catheters) for the treatment of traumatic hemothorax.]]></googleplay:description>
	<googleplay:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2021/08/pigtail.png?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>The ED-AWARENESS Study</title>
	<link>https://ccpem.blog/podcast/the-ed-awareness-study/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-ed-awareness-study&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-ed-awareness-study</link>
	<pubDate>Fri, 16 Jul 2021 14:38:13 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1577</guid>
	<description><![CDATA[<p>Ventilated ED patients may be at high risk for awareness with paralysis, thereby increasing the risk of long-term psychological sequelae.&nbsp; In this podcast, we discuss the results of the recently published ED-AWARENESS Study and its implications for managing the ventilated ED patient.</p>]]></description>
	<itunes:subtitle><![CDATA[Ventilated ED patients may be at high risk for awareness with paralysis, thereby increasing the risk of long-term psychological sequelae.&nbsp; In this podcast, we discuss the results of the recently published ED-AWARENESS Study and its implications for ]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Ventilated ED patients may be at high risk for awareness with paralysis, thereby increasing the risk of long-term psychological sequelae.&nbsp; In this podcast, we discuss the results of the recently published ED-AWARENESS Study and its implications for managing the ventilated ED patient.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1577/the-ed-awareness-study.mp3" length="32173637" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Ventilated ED patients may be at high risk for awareness with paralysis, thereby increasing the risk of long-term psychological sequelae.&nbsp; In this podcast, we discuss the results of the recently published ED-AWARENESS Study and its implications for managing the ventilated ED patient.]]></itunes:summary>
	<itunes:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2021/07/awqare.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i1.wp.com/ccpem.blog/wp-content/uploads/2021/07/awqare.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>The ED-AWARENESS Study</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:22:20</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Ventilated ED patients may be at high risk for awareness with paralysis, thereby increasing the risk of long-term psychological sequelae.&nbsp; In this podcast, we discuss the results of the recently published ED-AWARENESS Study and its implications for managing the ventilated ED patient.]]></googleplay:description>
	<googleplay:image href="https://i1.wp.com/ccpem.blog/wp-content/uploads/2021/07/awqare.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>The TTM2 Trial</title>
	<link>https://ccpem.blog/podcast/the-ttm2-trial/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-ttm2-trial&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-ttm2-trial</link>
	<pubDate>Thu, 01 Jul 2021 12:52:27 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">https://ccpem.blog/?post_type=podcast&#038;p=1549</guid>
	<description><![CDATA[<p>Current international guidelines recommend TTM for adult patients with ROSC from OHCA who remain comatose or unable to follow verbal commands.Â  However, the overall level of evidence for this recommendation remains of low certainty.Â  In this podcast, we discuss the results of the recently published TTM2 Trial and its implications on the management of post-cardiac arrest patients.</p>]]></description>
	<itunes:subtitle><![CDATA[Current international guidelines recommend TTM for adult patients with ROSC from OHCA who remain comatose or unable to follow verbal commands.Â  However, the overall level of evidence for this recommendation remains of low certainty.Â  In this podcast, w]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Current international guidelines recommend TTM for adult patients with ROSC from OHCA who remain comatose or unable to follow verbal commands.Â  However, the overall level of evidence for this recommendation remains of low certainty.Â  In this podcast, we discuss the results of the recently published TTM2 Trial and its implications on the management of post-cardiac arrest patients.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1549/the-ttm2-trial.mp3" length="38762287" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Current international guidelines recommend TTM for adult patients with ROSC from OHCA who remain comatose or unable to follow verbal commands.Â  However, the overall level of evidence for this recommendation remains of low certainty.Â  In this podcast, we discuss the results of the recently published TTM2 Trial and its implications on the management of post-cardiac arrest patients.]]></itunes:summary>
	<itunes:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2021/07/ttm2.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i0.wp.com/ccpem.blog/wp-content/uploads/2021/07/ttm2.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>The TTM2 Trial</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:26:54</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Current international guidelines recommend TTM for adult patients with ROSC from OHCA who remain comatose or unable to follow verbal commands.Â  However, the overall level of evidence for this recommendation remains of low certainty.Â  In this podcast, we discuss the results of the recently published TTM2 Trial and its implications on the management of post-cardiac arrest patients.]]></googleplay:description>
	<googleplay:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2021/07/ttm2.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Mechanical Ventilation in the Patient with ARDS</title>
	<link>https://ccpem.blog/podcast/mechanical-ventilation-in-the-patient-with-ards/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=mechanical-ventilation-in-the-patient-with-ards&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=mechanical-ventilation-in-the-patient-with-ards</link>
	<pubDate>Thu, 10 Jun 2021 14:49:18 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">http://ccpem.blog/?post_type=podcast&#038;p=1458</guid>
	<description><![CDATA[<p>More than 3 million patients develop ARDS each year across the globe.&nbsp; Like any therapy, mechanical ventilation can induce further lung injury and cause patient harm if misapplied.&nbsp; In this podcast we bring you up to speed on the latest, evidence-based titration of mechanical ventilation in patients with ARDS.</p>]]></description>
	<itunes:subtitle><![CDATA[More than 3 million patients develop ARDS each year across the globe.&nbsp; Like any therapy, mechanical ventilation can induce further lung injury and cause patient harm if misapplied.&nbsp; In this podcast we bring you up to speed on the latest, eviden]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>More than 3 million patients develop ARDS each year across the globe.&nbsp; Like any therapy, mechanical ventilation can induce further lung injury and cause patient harm if misapplied.&nbsp; In this podcast we bring you up to speed on the latest, evidence-based titration of mechanical ventilation in patients with ARDS.</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1458/mechanical-ventilation-in-the-patient-with-ards.mp3" length="50316995" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[More than 3 million patients develop ARDS each year across the globe.&nbsp; Like any therapy, mechanical ventilation can induce further lung injury and cause patient harm if misapplied.&nbsp; In this podcast we bring you up to speed on the latest, evidence-based titration of mechanical ventilation in patients with ARDS.]]></itunes:summary>
	<itunes:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2021/06/ards.jpg?fit=600%2C600&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i0.wp.com/ccpem.blog/wp-content/uploads/2021/06/ards.jpg?fit=600%2C600&#038;ssl=1</url>
		<title>Mechanical Ventilation in the Patient with ARDS</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:34:56</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[More than 3 million patients develop ARDS each year across the globe.&nbsp; Like any therapy, mechanical ventilation can induce further lung injury and cause patient harm if misapplied.&nbsp; In this podcast we bring you up to speed on the latest, evidence-based titration of mechanical ventilation in patients with ARDS.]]></googleplay:description>
	<googleplay:image href="https://i0.wp.com/ccpem.blog/wp-content/uploads/2021/06/ards.jpg?fit=600%2C600&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Early ED Sepsis Care</title>
	<link>https://ccpem.blog/podcast/early-ed-sepsis-care/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=early-ed-sepsis-care&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=early-ed-sepsis-care</link>
	<pubDate>Mon, 10 May 2021 18:34:59 +0000</pubDate>
	<dc:creator><![CDATA[Critical Care Perspectives in Emergency Medicine]]></dc:creator>
	<guid isPermaLink="false">http://ccpem.blog/?post_type=podcast&#038;p=1409</guid>
	<description><![CDATA[<p>Over 80% of patients with sepsis receive care in the ED.&nbsp; Despite evidence demonstrating the benefits of ED sepsis resuscitation, there remains significant controversies on many aspects of ED sepsis care.&nbsp; In this podcast, we are joined by EM/CCM extraordinaire Dr. Gabe Wardi, who discuss an upcoming article on ED sepsis resuscitation that will have a significant impact the care we provide to our patients.&nbsp; You cannot afford to miss this episode!</p>]]></description>
	<itunes:subtitle><![CDATA[Over 80% of patients with sepsis receive care in the ED.&nbsp; Despite evidence demonstrating the benefits of ED sepsis resuscitation, there remains significant controversies on many aspects of ED sepsis care.&nbsp; In this podcast, we are joined by EM/C]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Over 80% of patients with sepsis receive care in the ED.&nbsp; Despite evidence demonstrating the benefits of ED sepsis resuscitation, there remains significant controversies on many aspects of ED sepsis care.&nbsp; In this podcast, we are joined by EM/CCM extraordinaire Dr. Gabe Wardi, who discuss an upcoming article on ED sepsis resuscitation that will have a significant impact the care we provide to our patients.&nbsp; You cannot afford to miss this episode!</p>]]></content:encoded>
	<enclosure url="https://ccpem.blog/podcast-download/1409/early-ed-sepsis-care.mp3" length="56223803" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Over 80% of patients with sepsis receive care in the ED.&nbsp; Despite evidence demonstrating the benefits of ED sepsis resuscitation, there remains significant controversies on many aspects of ED sepsis care.&nbsp; In this podcast, we are joined by EM/CCM extraordinaire Dr. Gabe Wardi, who discuss an upcoming article on ED sepsis resuscitation that will have a significant impact the care we provide to our patients.&nbsp; You cannot afford to miss this episode!]]></itunes:summary>
	<itunes:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2021/05/sepsiscare.jpg?fit=1000%2C300&#038;ssl=1"></itunes:image>
	<image>
		<url>https://i2.wp.com/ccpem.blog/wp-content/uploads/2021/05/sepsiscare.jpg?fit=1000%2C300&#038;ssl=1</url>
		<title>Early ED Sepsis Care</title>
	</image>
	<itunes:explicit>clean</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:39:02</itunes:duration>
	<itunes:author><![CDATA[Critical Care Perspectives in Emergency Medicine]]></itunes:author>	<googleplay:description><![CDATA[Over 80% of patients with sepsis receive care in the ED.&nbsp; Despite evidence demonstrating the benefits of ED sepsis resuscitation, there remains significant controversies on many aspects of ED sepsis care.&nbsp; In this podcast, we are joined by EM/CCM extraordinaire Dr. Gabe Wardi, who discuss an upcoming article on ED sepsis resuscitation that will have a significant impact the care we provide to our patients.&nbsp; You cannot afford to miss this episode!]]></googleplay:description>
	<googleplay:image href="https://i2.wp.com/ccpem.blog/wp-content/uploads/2021/05/sepsiscare.jpg?fit=1000%2C300&#038;ssl=1"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>
	</channel>
</rss>
